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ABSTRACT 
 
The aim of the study was to determine the role of uNK cells by looking at their numbers 
across three location sites, the epithelial edge, areas of low stromal cell density/oedema and 
peri-vascular stroma/spiral arteries. The universal NK cell marker, CD56 was used to identify 
uNK cells in the endometrium. The research determined whether uNK cells were the result of 
proliferation and differentiation of resident uNK cells or trafficking of pbNK cells. In addition, 
it was determined whether uNK cells play a part in spiral artery remodelling and trophoblast 
invasion and also the role they may play in RM.  
 
The hypothesis was tested using Immunohistochemical staining on serial sequential sections 
of endometrial tissue received from RM patients of extreme phenotype between LH + 5-9 
days. Analysis was made on 20 RM patients, 10 patients were grouped as high uNK, defined 
as an uNK cell density value of ≥ 5% and 10 were grouped as low uNK, defined as an uNK cell 
density value of ≤ 2.5%. The endometrial samples were stained for the antibodies to CD56, 
KI67, NKp30, L-Selectin and CD16, uNK cell markers of proliferation, differentiation and 
trafficking.  
 
No association was found between RM and age. The high uNK density group had significantly 
higher levels for all the antibodies stained (P<0.0001). uNK cells were more proliferative and 
differentiated in the high uNK cell density group compared to the low. Proliferative and 
differentiated uNK cells also varied significantly across the location sites (P=0.003 and 
P=0.008 respectively). A significantly increased number of uNK cells staining positive for 
CD56, KI67 and NKp30 were found clustered around vessels (P=0.021, 0.001 and P=0.004 
respectively).  
 
The paucity of L-Selectin+ and CD16+ stained cells in both groups, low and high uNK cell density 
suggests that uNK cells are not trafficking from peripheral blood. Also, the spatial and temporal 
relationship of proliferative and differentiated uNK cells suggests that uNK cells originate from 
resident endometrial NK cells and do not arise from peripheral blood. In addition, KI67+ and 
NKp30+ uNK cells may assist with angiogenesis of uterine spiral arteries, which in turn increases 
uterine artery blood flow and subsequently initiates oxidative stress in the early developing foetus 
leading to RM.   
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CHAPTER 1 - INTRODUCTION 
 
1.1 PHYSIOLOGY OF REPRODUCTION 
 
The results of sexual reproduction pass through all aspects of mammalian life.  At the 
core of the process lies the creation and fusion of two gametes, the male sperm and the 
female ovum.  These gametes come together at fertilisation. Critical to sexual 
reproduction is the process of fertilisation.  
 
1.1.1 FERTILISATION (1) 
 
During sexual intercourse approximately 300 million sperm are released into the 
vagina. Only one sperm will fertilise the ovum. The successful sperm is one of many 
that swims through the cervical mucus, enters the uterus and passes up to the ampulla 
of the fallopian tube, the site of fertilisation. Both the female and male gametes have a 
limited period of viability in the female reproductive tract. Sperm are able to retain 
their fertility for up to 48 hours, whilst the ovum remains viable for only around 12 to 
24 hours after ovulation.  
 
Before a sperm fertilises an ovum it must undergo a process called capacitation. This 
occurs naturally within the female reproductive tract. The process of capacitation 
takes around 5 hours during which the composition of the plasma membrane of the 
sperm head is modified. The sperm which meet the ovum in the fallopian tube are 
confronted by the corona radiata, which makes up the outer layer of the egg. The 
corona radiata is a highly cellular layer with an intercellular matrix consisting of 
protein, carbohydrates and hyaluronic acid. After they have penetrated the corona 
radiate the sperm then undergo what is known as the acrosome reaction as they bind 
to the zona pellucida. The head of the sperm contains hydrolytic enzymes which are 
released together with the force generated by the tail of the sperm to help break 
through this surrounding layer, zona pellucida and penetrate the ovum. The most 
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important enzyme is acrosin, which is bound to the inner acrosomal membrane. Once 
the head of the sperm has made its way through the zona and into the perivitelline 
space, the space between the plasma membrane of the ovum and the zona pellucida, 
the tail falls off and the zona pellucida thickens further to prevent another sperm from 
entering. The sperm is now capable of fusing with the egg to complete the first stage 
of fertilisation. The fertilised egg then undergoes meiotic division which is normally 
completed within 2 hours of fertilisation. At this point the fertilisation is complete and 
the fertilised egg is known as a zygote. The process of fertilisation causes metabolic 
activation of the egg, which is necessary for cleavage and subsequent embryonic 
development to occur.  
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1.1.2 IMPLANTATION (1) 
 
The embryo, still encased in its zona pellucida, is transported down the fallopian tube 
and into the uterus. During this time and immediately after fertilisation the zygote 
undergoes a pronounced shift in metabolism and begins several days of cleavage. 
Development proceeds at the rate of one cleavage division per day for the first 2 days. 
After the two cell stage, one of the cells, also known as blastomere, divides now 
forming a 3 cells embryo. Continuing cleavage results in the 8-cell stage embryo which 
undergoes compactation, where the cells bind tightly to each other, forming a 
compact sphere. The embryo now consists of approximately 16 cells and is called a 
morula. The morula then becomes filled with fluid secreted by trophoblast cells, the 
outermost layer. A blastocoele has now been formed.   
 
Approximately six days later, the embryo sheds its zona pellucida allowing the embryo 
to expand. At this stage it is known as a blastocyst. This consists of an inner cell mass, 
also called an embryoblast which forms the amnion, yolk sac and allantois. This later 
gives rise to all the organs. The outermost layer, the trophoblast differentiates into 
two layers: the inner cytotrophoblast, a single layer of cuboidal cells and the outer 
syncytiotrophoblast. The blastocyst implants into the uterine wall by forming chorionic 
villi and lacunae that then fill up with maternal blood. This formation is assisted by 
hydrolytic enzymes that erode the epithelium.  
 
The syncytiotrophoblast secretes a glycoprotein hormone, human chorionic 
gonadotrophin (hCG) which initiates changes that can prevent regression of the corpus 
luteum and shedding of the endometrium. Maintenance of the corpus luteum will 
allow continuous secretion of progesterone which is required to maintain pregnancy. 
After 6-8 weeks the placenta is well established to synthesise and secrete sufficient 
progesterone to continue the remaining gestation period. The implantation process is 
completed by day 9 or 10. 
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Complex interactions involving hormones, cytokines and adhesion molecules between 
the blastocyst and the endometrium mediate implantation. During the mid secretory 
phase of the menstrual cycle the endometrium expresses factors required for 
implantation and undergoes cyclical changes. This period is known as the ‘implantation 
window’ and it occurs between 5 and 10 days after the LH surge (2). Following this 
phase the endometrium undergoes decidualisation, which results in the stromal cells 
changing. Although progesterone appears to be the main factor initiating 
decidualisation, a number of other factors, including cytokines, appear to facilitate this 
event. Malfunction at any point may lead to implantation or pregnancy failure. This is 
why the endometrial sample required for this research is taken at this important time 
of the menstrual cycle, during the ‘implantation window’. 
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1.1.3 PLACENTAL DEVELOPMENT (1) 
 
The placenta is a unique materno-foetal organ that connects the foetus to the uterine 
wall. It supplies the foetus with nutrients and oxygen and removes foetal waste via the 
maternal kidneys.  The placenta is made up of two parts, the foetal part (chorion 
frondosum) and the maternal part (decidua basalis).  At the placenta the foetal 
circulation comes close to the maternal circulation, but there is no actual contact or 
mixing of blood. The chorionic villi project towards the maternal decidua basalis. Each 
main villus becomes anchored to the decidua basalis, while secondary villi project into 
the intervillous space of the placenta. The intervillous space is subdivided by placental 
septa which cause the foetal surface to form units called the cotyledons. Spiral arteries 
supply the intervillous space with a pulsatile flow of maternal blood. The blood flows 
through the intervillous space to be drained from the placenta by endometrial veins. 
Branches of the umbilical arteries supply the villi with foetal blood. Blood flows 
through the capillaries of the villi, where gas exchange also occurs, to be collected in 
the branches of the umbilical vein to be returned to the foetal circulation. 
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1.1.4 ANATOMY OF PLACENTATION 
 
Transport occurs between the maternal blood circulation in the intervillous space and 
the foetal blood circulation. The extravillous trophoblast ensures the blood flow to the 
maternal intervillous space is sufficient enough to meet the demands of the foetus. 
This is achieved during early pregnancy when the extravillous trophoblast deeply 
infiltrates the uterine wall and the placental cells destroy the muscular walls of the 
uterine arteries. Also, the endothelium is replaced as the endovascular trophoblast 
cells move down the arteries. This replacement alters the vascular conductance and 
increased blood flow to the intervillous space results. This is required for normal foetal 
growth and development (3). It is important for trophoblast invasion to proceed deep 
enough to prevent many clinical conditions such as, pre-eclampsia, IUGR and still birth, 
which are a result of incomplete maternal vessel transformation and inadequate blood 
supply to the foetus later on in the pregnancy (4,5). A compromise between 
trophoblast invasiveness and maternal resistance is required for a normal pregnancy. 
There is close contact between mother and foetus as the trophoblast invades and 
arteries are transformed. Despite this intermingling, there is neither rejection of the 
foetus or parasitism of the mother, instead a balance is achieved and foetal and 
maternal cells form a definitive boundary that demarcates their respective territories.  
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1.2 RECURRENT MISCARRIAGE  
 
1.2.1 DEFINITION   
 
Miscarriage is a loss of a clinically recognised pregnancy at some point prior to the 
24th week of gestation. Recurrent miscarriage is defined as the spontaneous loss of 
three or more consecutive pregnancies, with the same biological father (6).  Recurrent 
miscarriage can be considered a primary or a secondary process. Primary recurrent 
miscarriage refers to repeated miscarriages, in which a pregnancy has never been 
carried to viability, whilst in secondary recurrent miscarriage, a live birth has occurred 
at some time.  
 
Other terminologies used are recurrent pregnancy loss, recurrent spontaneous 
abortion, recurrent spontaneous miscarriage, idiopathic miscarriage and habitual 
abortion.  
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1.2.2 EPIDEMIOLOGY 
 
Miscarriage occurs in 15-20% of all clinically diagnosed pregnancies of reproductive 
aged women, with the most occurring in the first twelve weeks of gestation. Recurrent 
miscarriage occurs in 1-2% of these women (7).  Prognosis for future successful 
pregnancy is affected by the previous number of miscarriages. The rate of miscarriage 
after one increases to approximately 20%; after two to 28%; after 3 to 48%, chances of 
a future successful pregnancy are around 2 in 3 once miscarriage has occurred (8,9).  
 
Maternal age also plays a significant role in the incidence of recurrent miscarriage. This 
suggests that pregnancy abnormality is a significant contributory factor to miscarriage 
given that the incidence of pregnancy abnormality increases with maternal (10). The 
risk of miscarriage for women younger than the age of 24 is 9.5%. With age this risk 
rises, it increases to 11% by the age of 30 and reaches 33% in women aged 40. The 
incidence increases dramatically to 53% in those women over the age of 44 (10,11). 
 
Pregnancy loss rates decrease as pregnancy progresses. Approximately 1 to 5 % are 
lost at 13 to 19 weeks' gestation, whereas stillbirth occurs in 0.3 % at 20 to 27 weeks' 
gestation, a rate similar to that of third trimester stillbirth. 
 
 
  
 9 | P a g e  
 
The Origin and Role of uNK Cells in patients with RM 
 
9 
1.2.3 IMPORTANCE OF RESEARCH 
 
Miscarriage is not fully understood by clinicians, some miscarriages just happen with 
no explanation other than nature 'taking a hand'. When this complex process of 
pregnancy goes wrong it can take a tremendous emotional toll.  
 
Clinical developments in the field of reproduction have expanded opportunities for the 
alleviation and circumvention of subfertility. The threat posed by miscarriage with no 
known aetiology continues to place reproduction high on the agenda of medical 
research.   
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1.2.4 CLASSIFICATION OF MISCARRIAGE (12-14)  
 
First trimester miscarriage is defined as a miscarriage which occurs within 12 weeks of 
gestation.  A blighted ovum is a very common type of miscarriage that accounts for 60 
percent of first trimester miscarriages. It is also known as empty gestation sac. This 
happens when a fertilised egg successfully attaches to the uterine wall but contains no 
embryo. All that forms is a placenta and an empty sac (14). A biochemical pregnancy is 
also a first trimester miscarriage which occurs when the foetus dies immediately after 
conception. This happens before the embryo has a chance to implant in the uterine 
wall. It produces a positive pregnancy test but is not seen on ultrasound. An embryonic 
loss is defined as an early embryo loss before foetal heart activity is visualised on 
ultrasound, usually before 8 weeks gestation, or the crown rump length is less than 5 
mm with no change seen on a rescan 7 days later (15). A foetal loss is said to occur 
when the foetus has died within 8-12 weeks gestation and no heart activity has been 
recorded (15). 
 
Second trimester miscarriage is defined as a pregnancy loss between 12 and 24 weeks 
of gestation (16). However, this is not as common as first trimester miscarriage. 
Pregnancy loss beyond 24 weeks gestation is known as stillbirth. Stillbirth is common in 
all countries around the world. In the UK, 5 out of every 1,000 babies will be stillborn. 
However, in the past thirty years the incidence of stillbirth has dropped considerably 
(17). Spontaneous second trimester loss is pregnancy loss with spontaneous rupture of 
the membranes or cervical dilatation. The foetus is between 12 to 24 weeks gestation 
and has had foetal heart activity (15). 
 
The clinical aspects of miscarriage are considered within six subgroups: threatened, 
inevitable, incomplete, complete, missed and septic miscarriage. Some treatment is 
discussed within each category.  
 
Threatened miscarriage is presumed when any vaginal bleeding appears in the first 
half of pregnancy. This is very common about 25-30% of all pregnancies have some 
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bleeding during the pregnancy (18). The bleeding is often small, but it may persist for 
days or weeks. The foetus at this point is still alive, the uterus is of expected size and 
the cervical os is closed. In 75% of women this will settle and 25% will go on to have a 
miscarriage. Threatened miscarriage is associated with risk of preterm rupture of 
membranes and preterm delivery. Women are told to inform their physicians 
immediately if any vaginal bleeding is observed. The bleeding generally ceases and a 
normal pregnancy results, therefore no intervention is usually taken place.  
 
Inevitable miscarriage is signalled by gross rupture of the membranes in the presence 
of cervical dilatation. Under these conditions miscarriage is almost certain. The 
bleeding is usually heavier, abdominal cramps occur and the cervical os is open. Most 
often, uterine contractions commence rapidly, resulting in expulsion of the products of 
conception. The possibility of salvaging the pregnancy is extremely unlikely. 
 
Incomplete miscarriage is where some parts of the foetus have been passed but the 
cervical os is open. The foetus and placenta are likely to pass together in miscarriages 
occurring before 10 weeks of gestation, but separately thereafter. Seen on ultrasound 
with an incomplete miscarriage, the retained products of conception may need to be 
removed by curettage.  
 
Complete miscarriage is defined by diminished vaginal bleeding. The entire foetus has 
been expelled, the uterus is no longer distended with pregnancy and the cervical os is 
closed.  
 
Missed miscarriage is when the undeveloped or deceased foetus is retained within the 
uterus and is not recognised until bleeding occurs or is seen on an ultrasound scan. The 
foetus is usually small for dates and the cervical os is closed. Mifepristone and 
misoprostol may be used to induce evacuation of products from the uterus. However, 
50% will require surgical evacuation.  
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Septic miscarriage usually presents as acute salpingitis. The contents of the uterus are 
usually infected, causing endometritis. Vaginal loss is frequently offensive and the 
uterus is tender. A fever may be absent. Abdominal pain and peritonism are suggestive 
of a pelvic infection. Broad spectrum antibiotics for example co-amoxiclav and 
metronidazole are usually started one hour prior to uterine curettage.  
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1.2.5 AETIOLOGY 
 
Isolated non-recurring chromosomal abnormalities account for 60 percent of sporadic 
miscarriages (19). However with recurrent miscarriage a maternal or paternal cause is 
more likely. There are many factors which need to be considered.  
 
1.2.5.1 FOETAL FACTORS 
 
Recurrent miscarriage at an early stage is commonly due to an abnormality in the 
development of the zygote, embryo, early foetus, or the placenta. Abnormal foetal 
development in the first trimester is classified into that with an abnormal number of 
chromosomes, known as aneuploidy, or an abnormal development with a normal 
chromosome number, known as euploidy.  
 
Pre-implantation genetic diagnosis has shown that women with recurrent miscarriage 
produce more aneuploid embryos than normal women (20,21). Approximately 50 to 
60 percent of recurrent miscarriages are associated with chromosomal anomaly of the 
conceptus (13). Another study reported one fourth of chromosomal abnormalities 
were due to maternal gametogenesis errors and 5 percent paternal. Less than 10 
percent were due to errors in fertilisation and zygote divisions (13).  
 
In sporadic miscarriage, autosomal trisomy is the most frequently identified 
chromosomal anomaly associated with first trimester miscarriages, with an incidence 
of 35 percent (22). 
 
Parental chromosomal anomalies occur in 4 percent of couples with recurrent 
miscarriage as opposed to 0.2 percent in the normal population (23). The most 
common is the result of balanced reciprocal or Robertsonian translocation, which 
produces an unbalanced translocation in the foetus (6,24). 
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Findings of an additional study were that a 100 percent of the pregnancies that 
miscarried had lower than expected crown rump length readings for their gestational 
age and in 61 percent of the women who miscarried, the foetus was significantly 
smaller than that expected for its gestational age (25). 
 
Research suggests euploid miscarriages are usually lost later in gestation. A study 
found three fourths of aneuploid miscarriages occurred at or before 8 weeks gestation, 
while euploid miscarriages peaked at 13 weeks gestation (13). 
 
1.2.5.2 MATERNAL FACTORS 
 
Maternal diseases are usually associated with euploid miscarriages (13). They have 
been associated with an increased risk for recurrent miscarriages. Maternal diseases 
include systemic lupus erythematosus, primary antiphospholipid syndrome, 
uncontrolled diabetes mellitus, thyroid disease, chronic essential hypertension, renal 
diseases and maternal infections such as Salmonella typhi, malaria, cytomegalovirus, 
brucella, toxoplasmosis, mycoplasma hominis, Chlamydia trachomatis and ureaplasma 
urealyticum (22). Current evidence is that well controlled thyroid disease and diabetes 
is not associated with recurrent miscarriage (23). Also bacterial vaginosis is associated 
with second trimester miscarriage, more so than first trimester miscarriage (8).  
 
1.2.5.3 ENDOCRINE FACTORS 
 
Some researchers believe imbalances in certain hormones such as lutenising hormone 
and progesterone play a role in recurrent miscarriage.  As already mentioned systemic 
maternal disorders, diabetes mellitus and thyroid dysfunction have been associated 
with miscarriage. 
 
Insufficient progesterone may be produced after ovulation, known as a luteal phase 
defect.  Progesterone is produced by the corpus luteum.  Progesterone is needed to 
sustain the endometrium to support an embryo and developing foetus. A luteal phase 
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defect is usually the result of suboptimal or poor ovulation. Treatment to improve 
ovulatory function with clomiphene citrate, or injectable FSH can help correct this 
problem. It can also be treated by administering supplemental progesterone. However, 
there has never been an RCT that shows this is an effective treatment.  
 
Luteinising hormone hypersecretion and polycystic ovarian syndrome are considered 
to be associated with recurrent miscarriage (26,27). However in a comparison study of 
recurrent miscarriage women with polycystic ovaries and women with normal ovarian 
morphology, the live birth rate was very similar, 58.5 percent and 60.9 percent 
respectively (23). 
 
Hyperprolactinaemia has been found to increase the risk of recurrent miscarriage and 
is also associated with unexplained infertility (28). Tal et al (29) reported that prolactin 
reduced the levels of HCG secreted from the placenta during early pregnancy (29). 
Hirahara (30) carried out a study looking at pregnancy outcome of recurrent 
miscarriage women with hyperprolactinaemia who were receiving bromocriptine for 
their condition. 85.7 percent of women had a successful pregnancy outcome 
compared to the control group of which was only 52.4 percent (30). 
 
1.2.5.4 UTERINE FACTORS 
 
The structure of the uterus can also affect the viability and the development of the 
foetus. Uterine abnormalities are split into congenital or acquired malformations. 
Congenital malformations include double uterus (uterus didelphysis), a singled sided 
uterus (unicornuate uterus), a heart shaped uterus (bicornuate uterus) and a septate 
uterus (midline muscle growth in the uterine cavity). Most of these abnormalities 
decrease the chance of pregnancy, increase the risk of miscarriage and also increase 
the risk of preterm labour. Research into pregnancy outcomes of women with 
abnormal uteri found that miscarriage is higher in women with a uterine abnormality 
than in those with a normal uterus, but these rates varied according to the type of 
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abnormality. Women with a septate uterus are at a greater risk of miscarriage than 
women with other abnormalities (31).  
 
Acquired abnormalities include uterine fibroids and intrauterine adhesions. Fibroids 
(uterine leiomyoma) are benign muscle growths that arise from the wall of the uterus. 
There are three types of fibroids: 1) submucosal, the fibroid is in or impinging into the 
uterine cavity, 2) intramural where the fibroid is within the wall of the uterus and 3) 
subserosal where the fibroid is primarily on the outside (serosal surface) of the uterine 
wall. Typically, submucosal fibroids are thought to significantly decrease the likelihood 
of conception by 50-80% and significantly increase the likelihood of miscarriage. 
Intramural fibroids have less of an impact unless they are greater than 2 cm in size. 
Submucosal fibroids probably do not have a major impact on miscarriage rates. 
Fibroids can usually be surgically removed. Uterine adhesions are usually the result of 
previous uterine surgery. This is primarily a complication of postpartum D&C (dilation 
and curettage) procedures but can also occur after intrauterine surgery for fibroids or 
polyps. 
 
Cervical incompetence is a known anatomical cause of recurrent miscarriage. It causes 
20 - 25% of miscarriages in the second trimester. Dilation and effacement of the cervix 
occur without pain or uterine contractions. Cervical incompetence occurs because of 
weakness of the cervix, which is made to open by the growing pressure in the uterus as 
pregnancy progresses. The causes of cervical incompetence include D&C and cone 
biopsy. Treatment is usually cervical cerclage, where a special suture is put into the 
weakened cervix to keep it closed until term.  
 
1.2.5.5 IMMUNOLOGICAL FACTORS 
 
The two mechanisms involved in the immunological factors of recurrent miscarriage 
are said to be either autoimmune or alloimmune. Autoimmune disorders are a result 
of an individual’s immune response to their own cells which results in destruction of 
their own cells. Examples of autoimmune diseases associated with recurrent 
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miscarriage include those that express antiphospholipid antibodies, including the lupus 
anticoagulant and anticardiolipin antibodies. These antibodies are directed against 
platelets and vascular endothelium, causing blood to clot more easily. It is thought that 
this results in improper blood flow in the placenta and the growing foetus does not 
receive the correct amount of oxygen and nutrition needed to survive and as a result, 
the foetus miscarries. There is evidence for an alternative mechanism by which 
antiphospholipid antibodies cause miscarriage, by their ability to directly inhibit 
trophoblast function (32). 
  
The prevalence of antiphospholipid syndrome (APS) in women with recurrent 
miscarriage is 15 percent (33). The live birth rate in these women with no 
pharmacological intervention is as low as 10 percent. However APS is a treatable cause 
of miscarriage. Various treatments include aspirin, heparin, steroids and intravenous 
immunoglobulin. Although a meta-analysis shows only a combination of aspirin and 
heparin can significantly improve the live birth rate in women with recurrent 
miscarriage and antiphospholipid syndrome (34). Pregnancy outcome is enhanced by 
54 percent with this treatment combination achieving over a 70 percent live birth rate 
amongst women with this syndrome (35). Although, there is one study that did not 
show a benefit of adding heparin to aspirin (36). However, the study used women with 
low anticardiolipin antibody levels and women were also assigned to the treatment 
group randomly at a late stage in their pregnancy where they were already likely to 
have a successful outcome. Moreover the use of pre-conceptual aspirin is 
controversial, recent publications have suggested that it causes harm.  
 
An alloimmune response is the result of an immune response to the cells of another 
member of the same species. For example the foetus is an allogenic transplant that is 
tolerated by the mother for reasons that are incompletely understood. However we 
know several immunological mechanisms occur to prevent rejection of the foetus. 
These mechanisms include histocompatibility factors, circulating blocking factors, local 
suppressor factors and maternal or antipaternal antileukocytotoxic antibodies (13) and 
many more which are not clearly understood. 
 18 | P a g e  
 
The Origin and Role of uNK Cells in patients with RM 
 
18 
 
All pregnant women have a higher chance of developing a potentially dangerous 
thrombus because of an increase in coagulation factors in normal pregnancy. The 
likelihood of having a pregnancy associated thrombus is at least 10 times higher for 
women with either or both of the two most common inherited blood clotting 
disorders, factor V Leiden or a prothrombin mutation. Approximately 10-15% of 
women who have recurrent miscarriages have an inherited thrombophilia. However, 
factor V Leiden carries a greater risk for miscarriage than a prothrombin mutation. 
There is up to a 30% chance of miscarriage in those who have factor V Leiden, 
compared to a 4 to 9% chance for those who have a prothrombin mutation (37).  
 
1.2.5.6 CHEMICAL AGENTS  
 
Exposure to teratogens increases the chance of miscarriage. Teratogens can be toxic 
chemicals and radiation, certain viral and bacterial infections, cigarette smoke and 
alcohol. A 2006 analysis (38) of past research found evidence that occupational 
exposures to these chemical agents could increase risk of miscarriage: heavy metals 
(industrial workers, dental assistants), organic solvents (laboratory, industrial, and dry 
cleaning workers), tetrachloroethylene (dry cleaning workers), glycol ethers 
(semiconductor employees), 2-Bromopropane (electronics industry), petrochemicals, 
ethylene oxide (dental assistants), anesthetic gases (surgical staff) and antineoplastic 
drugs (oncology staff). The first trimester is the period in foetal development that is 
most vulnerable to teratogens.  
 
Some viral and bacterial infections increase the risk of pregnancy loss. The ‘TORCH' 
infections (Toxoplasmosis, Rubella, Cytomegalovirus and Herpes); endometrial 
Infection and syphilis may be associated with miscarriage. Infections of the cervix or 
vagina such as Mycoplasma, Ureaplasma, Bacterial vaginosis, etc. have been 
associated with pregnancy loss. The incidence of infection in the UK during pregnancy 
is low. Rubella infection can be prevented by immunisation. Most bacterial infections 
are relatively easily treated with specific or broad spectrum antibiotics. Viral infections 
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(CMV, Rubella, Chicken pox, hepatitis, etc) and their association with recurrent 
miscarriages are less certain.  
 
A recent study showed that in women who have more than 200mg caffeine per day 
during pregnancy can increase the risk of miscarriage (39). 
 
 
1.2.6 CLINICAL FEATURES 
 
Most cases of miscarriage present with vaginal bleeding and lower abdominal cramps. 
Some may have lower back pain and pass products of conception and mistake this for 
clots. Some patients can present with shock due to the blood loss.  
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1.2.7 TREATMENTS 
 
Treatment suggested for recurrent miscarriage ranges from bed rest to the most 
recent advanced medical intervention discovered. However, there is no research on 
how bed rest may improve pregnancy outcome in recurrent miscarriage. Earlier 
scanning in subsequent pregnancies has also been suggested. This may reduce anxiety 
in women with recurrent miscarriage. It has been hypothesised that reducing anxiety 
can reduce immunological factors that may be seen as harmful to the developing 
foetus. Studies have suggested giving human chorionic gonadotrophin may be more 
effective at reducing recurrent miscarriages than placebo. HCG significantly reduced 
miscarriage compared with placebo, 14% with HCG vs. 40% with placebo (40). 
However the results may not be reliable since the review included studies of women 
with two or more consecutive miscarriages. Some studies did not provide information 
on how their patients were randomised or allocated. Another method of using 
intravenous immunoglobulin was suggested to improve pregnancy outcome. However, 
a systemic review of 8 RCT’s found no significant difference in live births between 
intravenous immunoglobulin treatment and controls (41).  
 
Recently low dose aspirin has been given to women with recurrent miscarriage, though 
it still remains controversial as to whether this offers any benefit. A systematic review 
found no significant difference in the live birth rate of women taking low dose aspirin 
and placebo. Low dose aspirin plus unfractionated heparin is more effective at 
reducing pregnancy compared with low dose aspirin alone. Paternal white cell 
immunisation and oestrogen supplementation has also been used as treatment for 
recurrent miscarriage. This has also proved no more effective than previous 
treatments mentioned at improving live birth rates (41).  A systematic review 
identified 3 RCT’s that gave progesterone to women with 3 or more consecutive 
unexplained miscarriages. The progesterone significantly reduced miscarriage rates 
compared with control, 25% vs. 47% respectively (42).  
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1.3 - IMMUNE SYSTEM OVERVIEW 
 
In the absence of a cause for this distressing condition researchers have explored 
several avenues to a successful treatment. One of these avenues is manipulation of the 
immune system. Cells making up the immune system develop from pluripotent 
hematopoietic stem cells at a gestational age of five weeks. As the foetus develops 
they circulate through various organs in the lymphatic system. The immune system 
protects from infection with defences of increasing specificity. Bacteria and viruses are 
prevented from entering via physical barriers. If a pathogen crosses these barriers, the 
innate immune system provides an immediate, but non-specific response. However, 
the adaptive immune system is activated if pathogens successfully evade the innate 
response. The recognition of the pathogen and is then retained in the immunological 
memory after it has been eliminated. The adaptive immune system can now respond 
faster and eliminate the pathogen more rapidly if encountered again. The immune 
system is divided into the innate immune system and the acquired or adaptive immune 
system (Table 1).  
 
Table 1: Comparing the differences between innate and adaptive immunity.  
Components of the immune system 
Innate immune system Adaptive immune system 
Antigen non-specific mechanism Pathogen and antigen specific response 
Exposure leads to immediate maximal 
response 
Lag time between exposure and maximal 
response 
Cell-mediated and humoral components Cell-mediated and humoral components 
No immunological memory Exposure leads to immunological memory 
Involves phagocytic cells: leukocytes, 
macrophages. Mast cells, NK Cells, 
complement proteins, acute phase 
proteins, interferons and cytokines.  
Involves macrophages, dendritic cells, B, T 
lymphocytes, cytotoxic T lymphocytes and 
cytokines. 
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Humoral immunity is mediated by secreted antibodies produced in B cells. The 
antibodies bind to antigens on the surfaces of invading microbes which flags them for 
destruction. It includes Th2 activation, cytokine production, memory cell generation, 
pathogen and toxin neutralisation, classical complement activation, and opsonin 
promotion of phagocytosis and pathogen elimination. Opsonins are molecules that 
coat the microbe and effectively mark them for their destruction. This enhances the 
efficiency of the phagocytic process.  
Cell mediated immunity involves the activation of macrophages, NK cells, antigen-
specific cytotoxic T-lymphocytes, and the release of many cytokines in response to an 
antigen. Cellular immunity provides protection by activating antigen-specific cytotoxic 
T-lymphocytes which induce apoptosis in cells displaying epitopes of foreign antigen 
on their surface. These include virus-infected cells, cells with intracellular bacteria, 
cancer cells displaying tumour antigens, activating macrophages and NK cells. They 
work by destroying intracellular pathogens. Cellular immunity also protects the body 
by stimulating cells to secrete a variety of cytokines that influence the function of 
other cells involved in adaptive and innate immune responses.  
Both components of the immune system depend on its ability to differentiate between 
self and non-self molecules. The immune system is able to distinguish self molecules 
from foreign. Conversely, non-self molecules are those recognised as foreign 
molecules.  
  
 23 | P a g e  
 
The Origin and Role of uNK Cells in patients with RM 
 
23 
1.3.1 CELLS OF THE IMMUNE SYSTEM (43,44) 
Phagocytes are subdivided into neutrophils and macrophages. They both have the 
same function, to engulf microbes. Neutrophils have a multilobular nucleus and play a 
role in the development of acute inflammation. They are also categorised as 
granulocytes since they contain granules which include acidic and alkaline 
phosphatases, defensins and peroxidise, all which are required to eliminate the 
unwanted microbe. Macrophages (also known as monocytes if found in the blood 
stream) are large cells with a horse shoe shaped nucleus. Its properties include 
phagocytosis and antigen presentation to T cells. Unlike neutrophils which are short 
lived, these cells are found in chronic inflammation since they are long lived cells.  
Mast cells and basophils are very similar in nature. In the cytoplasm they both contain 
electron dense granules. Unlike mast cells which reside in close proximity to blood 
vessels in connective tissue, basophils are present in the circulation.  Both cell types 
are involved in the initiation of an acute inflammatory response. Release of pro-
inflammatory mediators including histamine and various cytokines is achieved by 
degranulation. This is achieved by binding to components of the complement system 
or by cross linkage of IgE antibodies.  Histamine release induces vasodilation and 
enhances vascular permeability, whilst cytokines attract neutrophils and eosinophils. 
Eosinophils are granulocytes with a multilobed nucleus that also possess phagocytic 
properties. Even though they make up 2-5% of the total leukocyte population, they are 
involved in the eliminating parasites that are too big to be phagocytosed.  
 
Dendritic cells consist of Langerhans’ and interdigitating cells. They form an important 
bridge between innate and adaptive immunity. They are also known as antigen 
presenting cells as they present the antigenic peptide to the T helper cell.  
 
There are 3 major molecules of the immune system. They are the complement, acute 
phase proteins and interferons. The complement system is made up of a large group of 
independent proteins secreted by hepatocytes and monocytes. The complement 
system consists of two pathways, an alternative and a classical pathway.  Alternative 
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pathway is activated by the microbe itself and the classical pathway requires 
interaction of the antibody with a specific antigen. The complement system has the 
following functions, opsonisation, lysis (destruction of cells by damage or rupture of 
the plasma membrane), chemotaxis (migration of immune cells) and initiation of 
inflammation via direct activation of mast cells. Complement regulation is important to 
protect host cells from damage or total destruction. Acute phase proteins are 
produced in high numbers by the hepatocytes in response to cytokines released by 
macrophages. Interferons are molecules which prevent the spread of viral infections. 
They are split into two categories, type I and type II. Type I are further divided into IFN-
α and β. IFN-γ is the only type II interferon. Type I is induced by viruses, pro-
inflammatory cytokines and endotoxins from gram negative bacterial cell walls. Type II 
is produced by T helper cells and NK cells and includes both antigen presenting 
properties and phagocytic properties.  
 
Lymphocytes include T, B and NK cells. However, only T and B exhibit memory and 
specificity. B lymphocytes react with the free antigen directly when it binds to their cell 
surface immunoglobins which act as receptors, whereas T lymphocytes make use of 
APC’s to phagocytose the antigen and then express its component protein on the cell 
surface. This needs to occur in order for the T cell to recognise the antigen.  
 
T cells are divided into helper T (TH) and cytotoxic (TC) T cells. TH is further subdivided 
into TH1 and TH2. The former stimulate macrophages and are pro-inflammatory T cells, 
whilst the latter manage B cell differentiation and maturation and hence are involved 
in the production of humoral immunity. The third T-helper cell population is that of the 
TH0 cells; these are precursor cells which can be converted to either TH1 or TH2 type cells 
and can produce TH1 and TH2 cytokines as well as TNF-α and granulocyte-macrophage 
colony stimulating factor (GM-CSF) (45).  
 
T cells express cell surface proteins, TH cells express CD4 molecules on their cell surface 
which allows lymphocytes to bind to MHC class II molecule. The T cell receptor can 
only identify antigen when it is associated with MHC class molecules on the surface of 
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the cell.  Cytotoxic T cells are involved in the destruction of infected cells, i.e. viruses. 
Unlike helper T cells, cytotoxic T cells posess CD8 surface molecules which bind to 
antigenic peptides expressed on MHC class I molecules. Considerable interest into the 
role of cytokines in pregnancy has developed over recent years. TH2 cytokines are 
found to favour successful pregnancy, whilst TH1 cytokines are considered to be 
detrimental (46). Although the original hypothesis was based on T helper cell cytokine 
production.  
 
B cells are lymphocytes that produce antibodies (immunoglobulins) and can recognise 
free antigens directly. They originate from the bone marrow and migrate to secondary 
lymphoid organs. B cells are responsible for humoral immunity. B cells mature in 
antibody secreting plasma cells once they are activated by a foreign antigen. Not all B 
cells proliferate and develop into plasma cells. Clonal selection allows a significant 
proportion to remain as memory B cells. This vital process eliminates the antigen if in 
the future the body became re-exposed to it. T cells are also clonally selected to form 
memory T cells. Both T and B cells are able to re-circulate and migrate around the 
body, which increases the efficiency with which cells of the immune system can home 
onto the invading antigen. Antibodies play two roles, firstly to bind with the antigen 
and the second is to interact with host tissues and effector systems to ensure removal 
of the antigen (44). 
 
Major histocompatability complex (MHC) are cell surface proteins classified as class I 
(also known as human leucocytic antigen [HLA] A, B and C) which are found on all 
nucleated cells and class II (also known as HLA, DP, DQ and DR) which are found on all 
antigen presenting cells (APCs). MHC molecules are the outcome of T cell induced 
immunity.  
 
Natural Killer cells are also known as large granulocytes which are mainly found in the 
circulation. They make up 5-15% of the total lymphocyte population (44). They have 
receptors to IgG and also contain two unique cell surface receptors known as killer 
activation receptor (KAR) and killer inhibition receptor (KIR). Activation of KAR initiates 
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cytokine ‘communication’ molecules from the cell and activation of KIR inhibits this 
action. NK cells play an important role in destroying virally infected cells in addition to 
certain tumour cells. The granules within the NK cell release perforins and granzymes 
which induce apoptosis of the infected cell. NK cells also secrete IFN-γ which serves 
two purposes, first, to prevent healthy host cells from being infected by a virus and 
second, to enhance the T cell response to other virally infected cells.  
Cytokines, also known as interleukins (meaning ‘between white blood cells’) are small 
molecules which act as a signal between cells (Table 2). Cytokines play a role in 
chemotaxis, cellular growth and cytotoxicity. They have been described as ‘hormones’ 
of the immune system due to their ability to control immune activity.  
Cytokine Source Function 
IL-1 Macrophages Inflammatory response, 
Increase adhesion factor 
expression on endothelial 
cells 
IL-2 TH1 cells Stimulates cytotoxic T Cells 
IL-4 TH2 cells 
Mast cells 
B cell activation 
IL-5 TH2 cells B cell activation 
IL-6 TH2 cells B cell activation 
IL-8 Macrophages  
T cells 
Fibroblasts 
Keratinocytes 
Chemotaxis of PMNs 
 
IL-10 TH2 cells 
Macrophages  
B cell activation 
Suppress macrophages 
IL-12 B cells  Stimulate TH1 
Inhibit TH2 
TGF β (transforming 
growth factor) 
T cells  Inhibits other cytokines 
TNF α (tumour necrosis 
factor) 
Macrophages Inflammation 
TABLE 2: Highlighting the various types of cytokines, where they come from and the role they play in the 
immune system.  
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1.3.2 PREGNANCY AND THE IMMUNE SYSTEM 
 
Pregnancy is a biological paradox. Genetically foreign material will be rejected by the 
mother’s immune system. However, the immune system yet does not reject a 
genetically foreign foetus, which implants into the uterine wall and establishes an 
intimate contact with the maternal blood supply. For years now it has been speculated 
that a defect in the mother’s immune system towards the allogenic foetus may be 
involved in the mechanism of recurrent miscarriage.  Maternal Cytotoxic T cells are 
said to be inhibited during pregnancy, this allows the foetus to avoid rejection by its 
mother. However this finding was discovered in a previous study involving mice. 
Recent work in humans has suggested that immunity of pregnancy is likely to be much 
more complicated. Although there are changes in the levels of T-cell during pregnancy, 
the first phase is localised in the uterus and is mediated by the mother’s NK cells (44).  
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1.3.3 IMMUNOLOGY OF THE FETO-MATERNAL INTERFACE 
 
The only site of direct contact between foetus and the mother is at the feto–maternal 
interface in the uterus. The trophoblast for many years has been seen to act as a 
barrier between the transport of maternal and foetal cells. The interface is made up of 
trophoblast cells on the foetal side and immune-competent cells and decidual tissue 
on the maternal side. All important immune reactions occur between these cells at the 
interface. Consequently, the antigens and other immunological markers expressed by 
them will be of considerable interest (47). 
 
The maternal interface protects the pregnancy from the maternal immune system. The 
placenta also uses many mechanisms to avoid being rejected by the mother’s immune 
system. Neurokinin B containing phosphocholine molecules are secreted as well as 
small lymphocytic suppressor cells which inhibit maternal Cytotoxic T cells by inhibiting 
the response to interleukin 2. The foetus also secretes immunosuppressive agents such 
as platelet-activating factor, hCG, early pregnancy factor, immunosuppressive factor, 
prostaglandin E2, interleukin 1-α, interleukin 6, interferon-α, leukaemia inhibitory 
factor and colony stimulating factor, which all help avoid rejection by the immune 
system of the mother. 
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1.4 - NATURAL KILLER (NK) CELLS 
 
NK cells are specific lymphocytes which originate from stem cell precursors in the bone 
marrow and are a part of the innate immune system. They acquire cytotoxic qualities. 
NK cells secrete several cytokines (e.g. IFN-γ, IL-1, tumour-necrosis factor α *TNF-α+), 
and are a major source of IFN-γ. By secreting IFN-γ, NK cells can promote 
differentiation of type 1 helper T (TH1) cells and inhibit that of type 2 (TH2) cells. NK cells 
also recognise target cells by the decreased or absent expression of MHC class I 
molecules. NK cells are able to differentiate between self and foreign by the presence 
or absence of MHC class I molecules. Non-infected cells express MHC class I molecules 
on their surface, but virus-infected and malignant cells have a reduced expression, so 
NK cells will eliminate the cells that are infected. Many viruses and tumour cells use 
this tool to evade detection. NK cells are an active subject of investigation because 
they are able to differentiate between self and non-self molecules, a process that goes 
awry in diseases associated with the immune system.  
A network of specific activating and inhibitory receptors tightly regulate NK cell 
function. In particular, CD69 is one of the earliest cell surface activation markers 
expressed by NK cells. NK cells also express a variety of killer inhibitory receptors (KIRs) 
and killing activating receptors (KARs), which recognize HLA-G expressed on extra 
villous trophoblast (48). 
Peripheral blood and the uterine mucosa each contain NK cells, but the cells in these 
two areas have important phenotype and functional differences and therefore should 
be considered as separate lymphoid subsets.  
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1.4.1 PERIPHERAL BLOOD NK (pbNK) CELLS  
Typical pbNK cells make up 5 to 15% of mononuclear cells. They induce apoptosis of 
infected or abnormal cells by a number of pathways. NK cells originate from the bone 
marrow.  After differentiation, they enter into the peripheral circulation at a very early 
stage of maturation (49). They are cells of the innate immune system and therefore 
they lack antigen-specific receptors and immunological memory. pbNK cells are best 
characterised by CD2+, CD3-, CD4-, CD8+, CD16+and CD56 + surface markers. The cell 
surface antigen CD16 is expressed on the majority of cells and is a low affinity receptor 
for IgG complexes. It is responsible for NK-mediated, antibody-dependent cellular 
cytotoxicity.  
Based on the intensity of the CD56 expression, pbNK cells are divided into two 
populations: CD56dim and CD56bright.  
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1.4.2 UTERINE NK (UNK) CELLS  
The presence of granulated cells within the human endometrium has been recognised 
since the 1920s and several later reports described their distribution and staining 
characteristics (50). It should be remembered, however, that at least in humans uNK 
cells are not really ‘uterine’ but ‘endometrial’, being absent in myometrium.  NK cells 
are the most abundant immune cells infiltrating the endometrium. 70% of infiltrating 
leukocytes are CD56brght NK cells, together with some macrophages and a small 
number of T cells. B cells are practically absent (48). uNK cells are best characterised by 
CD56bright, CD16-, CD3- and CD4- antigens (50-52). 
After ovulation, uNK cells proliferate vigorously so that by the late secretory phase 
they account for at least 30% of the endometrial stroma (53). Endometrial derived IL-
15 and prolactin have been implicated in the proliferation and differentiation of these 
cells. They are both produced by the mucosal stromal cells and their expression is 
upregulated by progesterone (54,55). Mice lacking genes for the common β chain, 
common γ chain or IL-15 display severe deficiency of uNK cells, suggesting that IL-15 
receptor signalling is essential for uNK cell differentiation (56). 
uNK cells contribute to the cytokine response at the materno-foetal interface either as 
a TH1 or a TH2 type cytokine response. Normal pregnancy is said to be the result of a TH2 
type cytokine response, in which blocking antibodies disguise foetal trophoblast 
antigens from immunological recognition by a maternal TH1 cell-mediated cytotoxic 
response (46). By contrast, women with RM tend to produce a predominantly TH1 type 
response both in the period of embryonic implantation and during pregnancy (57-59). 
These findings support the view that disturbances of the immune tolerance of the 
foetus could contribute to RM. 
The pattern of expression of inhibitory receptor CD94/NKG2A found on uNK cells for 
which the ligand is HLA-E has shown that it is different from the expression pattern of 
pbNK cells taken from the same woman at the same time. Maternal cells and 
trophoblast cells both express HLA-E, this interaction might prevent the lysis of any 
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tissue cells (either maternal or foetal) in the vicinity (60). Receptors for HLA-C have 
also been found to be expressed by uNK cells (61-65). These are members of the KIR 
multigene family. They regulate the killing function of NK cells by interacting with MHC 
class I molecules, which are expressed on all cell types. This interaction allows them to 
detect virally infected cells or tumour cells that have a characteristic low level of Class I 
MHC on their surface. Most KIRs are inhibitory, meaning that their recognition of MHC 
suppresses the cytotoxic activity of their NK cell. KIR’s that are specific for HLA-C are 
expressed by a greater proportion of uNK cells of pregnant women compared to pbNK 
cells, which indicates that NK cell receptor repertoire is skewed towards recognition of 
HLA-C in the uterus (66,67). Interaction should occur between foetal HLA-C and 
maternal KIR’s during pregnancy (67). KIR molecules are highly polymorphic meaning 
their gene sequences differ greatly between individuals, therefore each pregnancy will 
involve different combinations of foetal HLA-C and maternal KIR’s, it is possible that 
some combinations may be less optimal for implantation and therefore these 
pregnancies fail.  
Moreover, polymorphisms in KIR molecules on uNK cells in combination with specific 
polymorphisms in their ligand on fetal trophoblast have been associated with pre-
eclampsia, a poor trophoblast invasion (68,69).   
The presence of this unique type of lymphocyte in the uterus at implantation and 
during early placentation is intriguing. Despite much speculation, the function of 
uterine NK cells is completely unknown. However, it has been suggested that uNK cells 
may be relevant to that pathogenesis of recurrent miscarriage. For example, Women 
with RM have a higher number of uNK cells compared to controls, and those with 
higher numbers have a correspondingly higher rate of miscarriage in subsequent 
pregnancies without treatment (69-71). These findings have prompted us, and others, 
to examine uNK cells in detail. An overview of uNK cells is now given to set the scene 
for the experimental work in this thesis. 
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1.4.2.1 RECEPTOR EXPRESSION OF UNK CELLS 
A series of studies in mice, humans and in vivo suggest that uNK cells are hormonally 
regulated (72). As uNK cells increase in number in the mid-luteal phase of the 
menstrual cycle, they were at first thought to be controlled by progesterone. The 
menstrual cycle dependent variation of uNK cells bears a resemblance to that of serum 
progesterone concentration, suggesting the involvement of progesterone in the 
proliferation of these uNK cells. 
 
However, uNK cells do not express progesterone receptors but do express the 
prolactin receptor, oestrogen receptor β and glucocorticoid receptors (54,73). It has 
been thought that progesterone shows a low avidity to glucocorticoid receptors (74). 
For this reason, ovarian steroids have been considered to have the potential to 
stimulate in situ proliferation of uNK cells directly. uNK cells may be regulated by the 
action of oestrogen via oestrogen receptor β or by progesterone via a receptor that is 
yet to be discovered. Although, a study which used isolated uNK cells found that 
neither progesterone nor β-estradiol affected the proliferation activity, cytolytic 
activity or cytokine secretion of these uNK cells in vitro (75). It is therefore unlikely that 
ovarian steroids directly affect in situ proliferation of uNK cells at a physiological 
concentration. 
 
Prolactin is produced by endometrial stromal cells between the mid and late-secretory 
phase. In the event of pregnancy prolactin synthesis increases significantly and peaks 
at around 20–25 weeks gestation (76). It is believed that the prolactin plays an 
important role in implantation and the maintenance of pregnancy. The pattern of 
expression of prolactin corresponds with the temporal rise in uNK cell number during 
the luteal phase and in pregnancy, suggesting a possible role of prolactin in this 
process. The precise function of prolactin on uNK cells remains to be uncertain, though 
it may regulate uNK cell proliferation or maturation (54). The prolactin receptor was 
identified on uNK cells by in situ immunofluorescence and in purified decidual NK cells 
by real-time PCR and Western blot analysis. Therefore, through inducing extracellular 
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signal-regulated kinases (ERK) phosphorylation directly on uNK cells, prolactin may 
regulate their differentiation and proliferation (54).  
 
Alternatively, uNK cells could be regulated by an indirect mechanism within which 
progesterone acts on the endometrial T cells and stromal cells, affecting VEGF and 
macrophage inflammatory protein-1β to enhance recruitment of uNK cells to the 
uterus, as well as acting through prolactin, via IL-15, to increase proliferation and 
differentiation of uNK cells (72). Several cytokines have been shown to stimulate the 
proliferation of uNK cells in vitro. One of these is cytokines is IL-2 (77), but IL-2 is not 
evident in the non-pathologic human endometrium and decidua (78,79). IL-12 also has 
the potential to stimulate proliferation of uNK cells, but in parallel, IL-12 stimulates 
their cytolytic activity (80). Stem cell factor may be a candidate cytokine expressed in 
the human endometrium (81) but alone, in the absence of IL-2 or IL-15, stem cell factor 
cannot stimulate proliferation of uNK cells (82). Lymphotoxin-β receptor, a TNF-α 
receptor family, considered essential for NK cell differentiation in bone marrow of 
murine models (83), was found expressed in all cell types in the human endometrium. 
However, its expression in the human endometrium did not vary with menstrual cycle-
dependent fluctuation. From these findings, these cytokines are less likely to be the 
involved in in situ proliferation of uNK cells. 
 
IL-15 is considered a T cell growth factor which shares several properties with IL-2 (84). 
IL-15 is believed to selectively stimulate proliferation of pbNK cells compared with 
other peripheral blood lymphocytes (85) IL-15 also stimulates uNK cell proliferation 
without increasing its cytolytic activity against trophoblasts (67,86). IL-15 protein is 
rarely detected even though it is expressed largely in various organs (84). IL-15 is 
expressed in the human endometrium at the protein level. There is a higher expression 
of IL-15 in the secretory phase of the endometrium compared to the proliferative 
phase. It originates from endometrial epithelial cells, macrophages and peri-vascular 
stromal fibroblasts. The production of IL-15 by the endometrial stromal fibroblasts in 
vitro is enhanced by progesterone (75). These findings suggest that IL-15 is a strong 
possible stimulator for in situ proliferation of uNK cells.  
 35 | P a g e  
 
The Origin and Role of uNK Cells in patients with RM 
 
35 
Stem cell factor or IL-18 may assist with IL-15, but no evidence exists that IL-18 single-
handedly stimulates the proliferation of uNK cells (87). It is possible that IL-15 is 
produced by progesterone stimulation from endometrial stromal fibroblasts which, in 
turn, stimulates the proliferation of uNK cells (88). 
 
In favour of in situ proliferation of uNK cells is their expression of a cell proliferation 
associated nuclear marker, Ki67. Immunohistochemical studies carried out on frozen 
endometrial sections and purified cells have established that up to 40% of CD56+ uNK 
cells that are isolated from late secretory phase of the endometrium express the 
antigen for Ki67 (89). 
The expression of three natural cytotoxicity receptors (NCRs) NKp30, NKp44, NKp46 
and NKG2D, also known as activating receptors on uNK cells in the endometrium have 
not been looked at in a great deal. Although, it has already been found that all the 
activating receptors mentioned are expressed in the pregnant decidua and instead of 
triggering cytotoxicity, these receptors act to stimulate secretion of cytokines and 
angiogenic factors essential for trophoblast invasion and vascular remodelling (90).   
A study found an increase in the expression of NKp30 and NKp44 on uNK cells in the 
presence of IL-15. However, these results suggest that uNK cells may exist as immature 
subsets which differentiate once activated. uNK cells are said to be inert lymphocytes 
in the endometrium that are incapable of killing target cells or secreting NK known 
cytokines and growth factors, before IL-15 activation (91). However these findings exist 
in vitro and may not necessarily reflect what is happening in vivo, this has yet to be 
investigated.  
Moreover, another study did find NKp30 to be selectively expressed in resting and 
activated NK cells.  NKp30 protein was localised to endometrial glands and luminal 
epithelium during early-, mid- and late secretory stages of the menstrual cycle and 
replacing the NKp30 antibody with an equivalent amount of control goat IgG resulted 
in the complete absence of immunoreactivity. The NKp30 protein was found to be 
expressed in high levels at the time of implantation, while hormonal regulation studies 
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showed that the expression NKp30 can be induced by progesterone. These 
observations suggest a possible role for NKp30 in the process of implantation (92).   
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1.4.3 uNK CELLS AND THE MENSTRUAL CYCLE 
The endometrium supports a variety of leukocyte populations whose numbers and 
proportions fluctuate cyclically with menstrual cycle stage. During the proliferative 
phase, leukocytes are less frequent and scattered. Ovulation, induced by a mid-cycle 
LH surge, terminates this phase, and leads to progesterone secretion from the corpus 
luteum and to leukocyte recruitment (93). As seen in Figure 1, uNK cells are maximal in 
number in the mid and late secretory phase when implantation occurs and continue 
into early pregnancy (50).  
 
 
Fig 1: The graph above highlights the relationship between uNK cell numbers in the decidua and gestational age. Placental bed 
cells were counted from pregnant hysterectomy samples (n = 35) (taken with permission from Bulmer and Lash 2005 (50)). 
 
uNK cells are small and agranular in the proliferative pre-ovulatory phase, then they 
proliferate and enlarge and become increasingly granulated in the post-ovulatory 
secretory phase. Two days before menstruation, when progesterone levels begin to 
decline uNK cells undergo nuclear changes of which cell death is indicated although 
the classical apoptosis features are absent. This morphological feature indicates that 
menstrual breakdown of the uterine lining will occur. During early pregnancy the uNK 
cells densely infiltrate around the trophoblast cells, but mid-gestation onwards they 
progressively decrease and by term they have significantly decreased (94). This 
presence of uNK cells coincides with trophoblast invasion and placentation, which is 
completed by 20 weeks gestation after which the uNK cells progressively disappear 
(48,95-97). 
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The fall of uNK cell numbers towards the end of pregnancy and also at the end of the 
menstrual cycle remains unexplained. However, cellular death by apoptosis and 
necrosis has been proposed for the loss of uNK cells in the later stages of mouse 
pregnancy (98) but no information is yet available concerning human pregnancy. 
Although a study has reported apoptosis of decidual leucocytes (99) another study 
failed to detect this in early human pregnancy (100). The possibility that uNK cells 
degranulate in late pregnancy has also been raised (101) to possibly account for the 
discrepancies in the number of CD56+ cells noted in immunohistochemical studies and 
the number of cells recognised in older studies by their cytoplasmic granules. 
However, it has been suggested that this could be addressed by analysis of perforin, a 
cytolytic protein found in the granules of NK cells, at different stages of pregnancy. 
Also the rounded hyperchromatic nuclei observed in uNK cells in the pre-menstrual 
endometrium has led to the proposal that these cells undergo apoptosis pre-
menstrually. However, a study found no evidence for this (102). Furthermore, it was 
found that the CD56+ cells once separated from the late secretory phase and 
premenstrual endometrium were still capable of proliferative activity and cytotoxicity. 
Up to 40% still expressed Ki67 indicating proliferation rather than apoptosis 
(89,103,104). 
On the other hand, uNK cells in the non-pregnant murine endometrium exist in a small 
number. They appear within 24 hours after embryo implantation (on gestational day 5) 
in the decidua basalis, mesometrial triangle and mesometrial lymphoid aggregates of 
pregnancy (these are lymphoid structures that develop in the myometrium at 
implantation sites surrounding uterine arterial branches). Murine uNK cells increase 
until gestational day 12, and then they start to degenerate between gestational days 
12–15 (94). The increase of murine uNK cells is seen also in the pseudopregnant 
uterus, i.e. the artificially induced deciduomata (105). 
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1.4.4 ROLE OF UNK CELLS 
The function of uNK cells is unknown. The temporal and spatial distribution of uNK 
cells suggests they contribute to the control of trophoblast invasion. Attention has also 
been directed at their possible role in structural adaptation of the uterine spiral 
arteries (53). Although, there is little information regarding the distribution of uNK 
cells in the second trimester, since tissues from this stage of normal pregnancy is 
unavailable. 
1.4.4.1 CONTROL OF TROPHOBLAST INVASION 
Invasion of uterine tissues and spiral arteries is an essential feature of successful 
pregnancy in humans (106). This invasion is tightly controlled; too much or too little 
invasion can cause pre-eclampsia, foetal growth restriction, preterm labour and 
miscarriage (106). Invasion of the trophoblast into the uterine wall occurs from 
implantation onwards. It extends by the end of the first half of pregnancy into the 
inner third of the myometrium. The uterine spiral arteries are invaded by the 
trophoblast cells, which then migrate within the lumen to as far as the inner third of 
the myometrium. The end result of the trophoblast invasion is the loss of the arterial 
media smooth muscle and elastin. The spiral arteries are now dilated vascular channels 
which are able to supply the low resistance and increased maternal blood supply 
required to the feto-placental unit and do not respond to any vasomotor influences 
(50).  
It has been proposed, due to their interaction with trophoblast cells in early pregnancy 
that uNK cells play an active role in the regulation of trophoblast invasion. Several 
mechanisms have been suggested for this association, they include cytotoxicity, local 
cytokine production and trophoblast apoptosis. Although many studies have found 
unlike pbNK cells, uNK cells possess very little cytotoxic activity against trophoblast 
cells without prior activation with IL-2 (107-110).  
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As already noted uNK cells are a rich source of many different cytokines and growth 
factors (111-114). Altered production of IFN-γ has been reported in decidua basalis 
compared with decidua parietalis (115,116) has reported an increase in the production 
of IFN-γ and VEGF by uNK cells in response to HLA-G. However, Ang-2 (an angiopoietin, 
a protein growth factor that promotes angiogenesis from pre-existing blood vessels) 
(117), TNF-α (118), IFN-γ and TGF-β1 (119) have all been shown to inhibit trophoblast 
invasion. Although the cytokines and growth factors produced by uNK cells have been 
studied using in vitro invasion assays. However, the overall effect of uNK cells on 
trophoblast invasion has not yet been investigated in detail.  
A study found 30% of trophoblast cells determined by immunostaining are undergoing 
apoptosis in the early gestational placental beds of women with uncomplicated 
pregnancies (50). Double immunohistochemical labelling has revealed that many 
apoptosing trophoblast cells are surrounded by uNK cells. Though, the stimulus for the 
initiation of apoptosis in the trophoblast cells still remains uncertain. The ability of uNK 
cells to initiate cellular apoptosis is poorly studied. Another probable explanation for 
the association between apoptosing trophoblast cells and uNK cells may be that the 
trophoblast cells which undergo apoptosis recruit uNK cells after apoptosis has been 
initiated. If uNK cells are believed to regulate trophoblast invasion then the mechanism 
by which this occurs is most likely mediated by uNK cell cytokine secretion (50). 
In about two-thirds of first trimester miscarriages there is histological evidence of 
premature onset of maternal blood flow into the intervillous space throughout the 
placenta (120,121). This blood flow is found to lead to a state of oxidative stress which 
is said to be associated with trophoblast apoptosis. This finding is independent of the 
foetal karyotype (122-124). 
There is no convincing evidence that uNK cells kill placental trophoblast cells. Instead, 
they are said to have an essential, beneficial effect on the trophoblast by secreting 
cytokines that alter the depth of placental invasion. Unlike T lymphocytes, NK cells are 
able to spontaneously kill cells in a non-MHC restricted manner. NK cells have a 
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misleading name in reproduction, and the powerful illustration of maternal cells 
attacking the foetus is controversial and easily exploited (53). 
1.4.4.2 CONTROL OF VASCULAR REMODELLING 
uNK cells have also been proposed to play a role in spiral artery transformation (94). 
Although most of the evidence for uNK cell involvement in spiral artery transformation 
has come from mouse models. For example, NK, T and B cell deficient female mice that 
do not have fertility problems but experience >50% foetal loss between 10 and 14 days 
post conception and of those that survive have a very small placenta and they remain 
small throughout their adult lives compared to controls. Also, there is a lack of 
remodelling of the uterine spiral arteries in these mice. However, transplantation of 
bone marrow from donors results in a reconstitution of uNK cells without a 
reconstitution of T cells. This reverses the reproductive deficiencies of the mice (125). 
It has also been demonstrated that the key uNK cell product accountable for the spiral 
artery remodelling defects is IFN-γ. Mice deficient in uNK cells or IFN-γ signalling have 
implantation site abnormalities and failure of artery remodelling. These defects are not 
overturned when the deficient mice are given bone marrow from IFN-γ deficient 
controls. This strongly suggests the function of uNK cells in mouse are mediated by 
IFN-γ (126). 
Much less is known concerning the mechanisms involved in spiral artery remodelling in 
humans. Early structural changes occur before cellular interaction with trophoblast 
such as dilatation in the spiral arteries (127) but at a time when uNK cells are present 
(95) uNK cells are seen to reduce in number after 20 weeks’ gestation when vascular 
changes are normally complete. In the placental bed uNK cells are seen to be very 
closely associated with non-transformed, transformed and transforming spiral arteries 
(50). 
 
In addition to IFN-γ, Ang-2 may be an important uNK cell derived mediator of spiral 
artery transformation. On binding to Tie-2 (the cell-surface receptor which binds and is 
activated by the angiopoietins) Ang-2 acts to counteract the effects of VEGF-A and 
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Ang-1 to destabilise vessel structure. It is only found to be expressed in tissues where 
vascular remodelling is taking place. uNK cells are a rich source of Ang-2 (114) and are 
found mostly in association with vessels undergoing remodelling in the placental bed. 
The mechanisms for spiral artery transformation are poorly understood due to a lack 
of appropriate human models for the study. Additionally, the changes that the 
remodelled vessels undergo are inadequately defined.  
 
uNK cells may affect the endometrium by controlling vascular function through 
secretion of angiogenic growth factors. In this way they may be crucial in the decision 
to switch from endometrial breakdown (menstruation) to decidualisation in pregnancy 
(128). Investigation of uNK cells in human pregnancy is held back by the lack of 
availability of tissues from the first half of the second trimester of pregnancy when 
vascular remodelling occurs and also by possible differences between cells from 
different regions of decidua (50). 
The following need to be considered before the role of uNK cells is established. uNK 
cells are confined to the endometrium, whereas trophoblast invasion and spiral artery 
transformation extends into the inner third of the myometrium where there are no 
uNK cells. A possible theory may be that uNK cells initiate the trophoblast invasion and 
spiral artery transformation. Also, Invasion by trophoblast occurs in ectopic 
pregnancies in the absence of uNK cells (129,130). It is difficult to assess whether this 
invasion is extreme given that the wall of the fallopian tube is not equivalent to that of 
the uterus and that the rupture of the fallopian tube may be due to mechanical 
reasons rather than excessive trophoblast invasion. uNK cells are also present in 
numerous species which do not go through invasive placentation and so an alternative 
role would need to be proposed for these. 
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1.4.5 UNK CELLS AND RM 
Many clinicians believe that some women with RM have an endometrial factor 
contributing to the pregnancy losses (23). Studies of the preimplantation endometrium 
have found differences in the uNK cell populations in women suffering idiopathic RM. 
Using flow cytometry, CD16–CD56bright NK cells were decreased and CD16+CD56dim NK 
cells were increased in the luteal phase endometrium from women who had suffered 
RM (69). With immunohistochemistry increased numbers of CD56+ cells were detected 
in the mid-luteal phase endometrium compared with fertile controls (70,71,131). 
Moreover, high numbers of uNK cells in women with RM were predictive of 
miscarriage in subsequent pregnancy (71). However there are two studies that have 
failed to confirm an association between uNK cells in RM (132,133) although they did 
include women with only two miscarriages. Though, others have found that women 
with just two miscarriages cannot be considered to be suffering from any pathology 
since they have such a high live birth rate (85%) in subsequent pregnancies (134-136). 
  
An association between high numbers of uNK cells and women with idiopathic RM of 
severe phenotype has been confirmed (131). Research has identified those women 
who have had a previous birth, have a significantly lower number of uNK cells 
compared to women who have not previously given birth. This is said to be the result 
of the complex process of pregnancy and birth which involves extensive changes in the 
size and vascularisation of the uterus. However, in a study of five women who all had a 
previous live birth had uNK cell numbers of >5%. This excludes the possibility that a live 
birth reduces the uNK cell numbers to <5% in all women regardless of whether they 
have given birth in the past (131). Much previous work on the endometrium of women 
with RM has suggested that a luteal phase defect may be involved. Luteal phase defect 
is believed to interfere with the implantation of embryos (23). The results of another 
study suggest that the increased numbers of uNK cells seen in the endometrium of 
women with RM are independent of luteal phase defects (137). 
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Two competing hypotheses have been suggested for how uNK cells may lead to RM. 
Firstly, uNK cells may be hostile to the invading trophoblast or secondly, uNK cells 
facilitate the implantation of abnormal blastocysts, which leads to the clinical 
presentation of RM (138). A problem with the first hypothesis is that uNK cells are 
needed for normal pregnancy to occur, at least in mice (139). There is uncertainty as to 
whether high numbers of uNK cells may be harmful and whether they should be 
decreased. The second hypothesis is supported by data which shows that uNK cells are 
more numerous in the decidua from chromosomally abnormal miscarriages than in 
those from chromosomally normal miscarriages (140). Differences were found in the 
decidual leucocytes from the miscarried women with unexplained RM and a normal 
foetal karyotype compared to women with unexplained RM and abnormal foetal 
karyotype (141). 
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1.4.6 PBNK CELLS AND RM 
 
Some studies have found an association between pbNK cells and RM. Studies have 
shown that women with unexplained RM have increased numbers and activity of pbNK 
cells and that increased levels of these cells predict subsequent miscarriages in women 
with RM (142,143). However, such increases may not reflect a condition of overactive 
immunity but may result from a transient increase in the number of NK cells because 
of the stress associated with blood withdrawal (144). 
However, one recent study found no significant difference in the number of pbNK cells 
between women with RM and control subjects. Only 5% of women with RM had high 
pbNK cells. The number of previous miscarriages did not appear to have an impact on 
the number of NK cells. Therefore it concludes that there is limited value in the routine 
measurement of pbNK cells in women with RM (145). 
Based on the alleged similarities between pbNK and uNK cells, it has become 
increasingly common to examine pbNK cells in women with RM and infertility. These 
tests are based on the theory that these women have abnormalities in uNK cell 
function, and it has been implied that these are apparent from analysis of pbNK cells 
(146,147). This approach has several problems. Firstly, as mentioned earlier, uNK cells 
are different from those in peripheral blood. Examination of pbNK cells will not tell us 
what is happening in the uterus.   
Secondly, it is unclear what an abnormal NK cell number is. The percentage of CD56+ 
pbNK cells in normal healthy individuals varies from 5% to 29% (148). Despite this, a 
finding of more than 12% pbNK cells in women with infertility or RM has been 
arbitrarily defined as the cut-off point for abnormally raised NK cells. Hence, 
individuals with entirely normal results are being labelled as having raised NK cell 
numbers and is used as an indication for treatment (149). Many factors are said to 
affect the percentage of pbNK cells, these include sex, ethnicity, stress, and age, but 
there is no indication that concentrations in the upper end of the normal range are 
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ever harmful. Furthermore, CD56 can also be expressed by activated T cells and NK T 
cells and the inclusion of these may alter results. 
Thirdly, NK cell activity is measured by a range of assays and the results vary in 
different laboratories. The most commonly used in vitro assay is cytotoxicity, which 
may not have much relevance to NK cell function in vivo. Certainly, in viral infection, 
NK cells function mainly by producing cytokines. Furthermore, uNK cells have a much 
lower cytolytic activity than pbNK cells. Thus, no clinically relevant information is 
gained from studying either the percentage or cytotoxicity of pbNK cells in women 
with pregnancy failure. Therefore it is important to look at uNK cells as a separate 
lymphoid subset to identify their origin, location and function to help achieve a better 
understanding of their role in women with RM and infertility.  
 
Patient’s expectations for an answers or even cures for their reproductive failures are 
ever increasing leaving them vulnerable to exploitation by those implementing new 
investigations and treatments that have little scientific validity. Some units have 
charged couples for pbNK cell estimations during the work up for recurrent 
miscarriage. No association between the levels of pbNK cells and uNK cells has been 
recorded, and levels of pbNK cells are not predictive of pregnancy outcome in women 
with unexplained RM. Therefore, the value of testing women with RM for levels of 
pbNK cells is questionable (53).  
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1.4.7 ORIGIN OF UNK CELLS 
The origin of uNK cells is unknown, but they are said to closely resemble the minor 
CD56bright pbNK cell population. One possible theory suggested for this is that the pbNK 
cells may move into the uterus, this is known as trafficking of pbNK cells. They are then 
said to undergo proliferation, differentiation and enlargement and acquire cytoplasmic 
granules (48). Another possible theory suggested is that haematopoietic progenitor 
cells that reside in the endometrium proliferate and differentiate into uNK cells (150). 
1.4.7.1 PROLIFERATION & DIFFERENTIATION 
In favour of in situ proliferation of uNK cells is their expression of a cell proliferation 
associated nuclear marker, Ki67. Immunohistochemical studies carried out on frozen 
endometrial sections and purified cells have established that up to 40% of CD56+ uNK 
cells that are isolated from late secretory phase of the endometrium express the 
antigen for Ki67 (89) and, stromal mitoses is a recognised feature of the pre-menstrual 
endometrium. Also, a dual immunohistochemical study demonstrated that the positive 
rate of Ki67 in uNK cells was higher in the secretory phase than in the proliferative 
phase (151). This was confirmed using three different methods (152). It is therefore 
possible that local proliferation of uNK cells could account for their dramatic increase 
in number. The increase in uNK cell number by local proliferation would have to be 
from stem cell precursors within the endometrium remaining after menstruation or 
from residual CD56+ cells in the stratum basalis which is not shed at menstruation, 
since at no point during the menstrual cycle is there any substantial number of CD16+ 
NK cells (50). Up-regulation of genes controlling proliferation has been found to occur 
in the luteal phase endometrium (153). 
In murine models uNK precursor cells have limited self-renewal capacity in the uterus 
but are capable of differentiating into mature uNK cells. Mature uterine NK cells show 
in situ proliferative capacity in mid-pregnancy (154,155). 
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1.4.7.2 TRAFFICKING  
Other researchers explain the increased number of uNK cells in the endometrium as an 
influx of pbNK cells from the circulation with modification to the specialised uNK cell 
type within the uterine microenvironment (50). Several studies believe expression of 
adhesion molecules by uNK cells in the endometrium could explain homing of uNK 
cells to the endometrium from peripheral blood and also may account for their 
distribution in a peri-vascular position (156-158). In both humans and mice uNK cells 
are seen in a collection around blood vessels. Since uNK cells are CD16-, recruitment 
from the blood would suggest recruitment of CD56bright NK cells or their precursors 
within the circulation which then undergo modification within the uterus.  
In the late secretory phase endometrium and early pregnancy uNK cells are detected in 
the stratum functionalis where they have been found often forming aggregates around 
spiral arteries and glands (95). This peri-vascular distribution was initially said to 
represent the effect of diffusion of progesterone from blood into peri-vascular tissues 
but more recently has been considered to reflect trafficking of uNK cells or their 
precursors from the peripheral circulation  (97,159). An alternative explanation is that 
the peri-vascular distribution may reflect a role in the remodelling of spiral arteries 
which is an essential feature of pregnancy.  
Another interpretation of the peri-vascular location of uNK cells is that they may have 
a role in decidualisation of stroma (50). 
 Evidence from mouse pregnancy supports trafficking of precursor cells to the uterus in 
early pregnancy in mouse (155). It is suggested that an increase in uNK cell number 
seen in decidualisation and implantation is a result of endocrine signals that co-
ordinate and recruit uNK stem cell precursors from the spleen into the uterus. Other 
studies have shown that steroids produced by the ovaries and the LH surge enhance 
the adhesive property of NK cells to the murine uterus using the L-Selectin dependent 
mechanism, although it remains unclear whether their effect is direct or indirect 
(93,159,160). These findings point towards that uNK cells in murine models are 
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established from NK-precursor cells recruited from the peripheral circulation into the 
implantation site, rather than exclusively from in situ proliferation. 
Overall these studies of murine uNK cells are based on in vivo assays. They give us 
many clues to the understanding of the underlying mechanisms in the post-ovulatory 
rise of human CD16- uNK cells. At the same time, uNK cells found in mice are different 
from those human endometrial CD16- uNK cells in several different ways. For example, 
murine uNK cells do not increase in number after ovulation, but they do after 
implantation. In addition, uNK cells also accumulate in the murine-specific placental 
structure (the mesometrial triangle and mesometrial lymphoid aggregates of 
pregnancy) and not only in the decidua basalis. Consequently, direct relevance of these 
findings to humans should be made cautiously (88). 
In humans implantation is a complex process composed of three distinct and 
consecutive phases: apposition, attachment, and invasion (161). Selectins are a group 
of cell adhesion molecules that include P-selectin (CD62P), L-selectin (CD62L), and E-
selectin (CD62E). Evidence indicates that in the uterus the initial attachment of an 
embryo to the endometrium depends on binding of L-selectin. This is expressed by the 
trophoblast and oligosaccharide-based ligands which are expressed by the 
endometrium (162). Interactions between L-Selectin and its respective ligand in the 
endometrium may behave as a bridge for the initial attachment during implantation 
(163). This supports the notion that the expression of L-Selectin ligands might reflect 
the receptivity of the endometrium. However the expression pattern of L-Selectin 
ligands in the human endometrial cycle remains indefinite. 
 
A study (164) looked into the L-Selectin ligand in the luminal and glandular epithelium 
of the endometrium at various phases of the menstrual cycle. L-Selectin ligand was 
expressed differentially at various phases in the endometrium. In the luminal 
epithelium, the expression of L-Selectin ligand was greatest from the peri-ovulatory 
phase through to the mid-secretory phase which coincides with the window of 
implantation. 
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However, in the glandular epithelium, L-Selectin ligand expression increased steadily 
from the proliferative phase to the secretory phase, the expression of L-Selectin ligand 
was greatest in the mid-secretory phase. The level of L-Selectin ligand was 
considerably elevated at the beginning of the secretory phase until 5–7 days post 
ovulation. 9-11 days after ovulation the level of L-Selectin ligand fell in both the 
luminal and glandular epithelium. This pattern is consistent with the concept that the 
luminal epithelium serves as an initial contact between the blastocyst and the 
endometrium, whereas the glandular epithelium participates at a later stage. It is 
possible that defects in the Selectin adhesion system may account partly for certain 
instances of implantation failure and early pregnancy loss (162). 
L-Selectin and their ligands that play a part in cell-to-cell interactions are essential in 
the rolling, tethering, and attachment processes which allow leucocytes to pass 
through the endothelial barrier to reach lymphatic organs and inflammation sites (165-
167). The binding of L-Selectin to its ligand may activate a signalling cascade (168) 
which in turn triggers signalling pathways that modify the uterine environment to 
allow a more stable adhesion of the embryo to the endometrium. L-Selectin may serve 
as a possible biochemical marker of endometrial receptivity and may help clarify the 
implantation process. Further evaluation of the L-Selectin is important to determine if 
it can help identify patients with defects in endometrial receptivity, unexplained 
infertility, and RM. 
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1.4.8 MARKERS USED IN THIS RESEARCH  
NK cells express receptors for many antigens, the following listed in table 3 are the 
ones that were stained for in this particular study. The following markers will help us 
understand the origin and the function of uNK cells in the endometrium. This may in 
future help us explain why women experience RM and implantation failure.  
NK cell Markers Evidence Implication in this research 
CD56 Universal NK Cell marker All NK cells will stain 
positive for this marker. 
CD16 90% of pbNK cells are 
CD16+, whereas only 
approximately 10% of uNK 
cells are CD16+ (169) 
If increase of CD16+ cells 
found in research samples, 
then uNK cells could 
possibly be the result of 
trafficking from peripheral 
blood 
CD62-L Is an adhesion molecule. 
May also be a marker of 
endometrial receptivity 
(164) 
If increased CD62-L+ cells 
then possibility that the 
endometrium displays 
adhesive properties that 
allow NK cells to home into 
the uterus from peripheral 
blood. i.e. support 
trafficking theory 
KI67 40% of CD56+ NK cells 
express the antigen for KI67 
in the secretory phase 
endometrium (89) 
If increased numbers of 
KI67+ Cells found in 
research samples stained 
then we can say that NK 
cells are proliferating and 
may result from resident 
uNK cells.  
NKp30 It is an 
activating/differentiating 
marker for all NK cells, 
belongs to the NCR family. 
Activated by IL-15 (91,92) 
We know it is expressed in 
decidual NK cells, but we 
want to know if uNK cells 
in the secretory phase 
endometrium express the 
marker NKp30.  
 
TABLE 3: NK Cell markers stained for in this particular study are highlighted above. Also highlighted is the 
evidence of how these cells were discovered and what implication the markers have in this study. 
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1.5 - CONCLUSION 
 
The latest research has given us an in-depth understanding of the complexities of an 
evolving pregnancy and of the potential hazards that it may face at different 
developmental stages. For many years it has been thought that RM is caused by 
maternal rejection of normal foetuses. However, recent evidence has challenged this 
assumption. The endometrial leukocyte profile in women with RM has recently been a 
focus of interest. Recent research has shown that high levels of uNK cells within the 
endometrium may be associated with idiopathic RM. uNK cells are seen to be the most 
abundant leukocytes in the endometrium. In order to improve both the management 
and research into RM, it is important to determine the role uNK cells play in the 
endometrium at implantation in patients with RM.  
The function of uNK cells is unknown and their role played in implantation remains 
unclear. Maternal uNK cells are adjacent to, and have the ability to interact directly 
with, foetal trophoblast cells. Their presence in the pre-implantation endometrium 
indicates that they are not simply part of an immune response to embryonic demise. 
Extensive trophoblast invasion of the uterine tissue is necessary for successful 
implantation and placentation. This process must be finely regulated.  
There is considerable controversy concerning the origin and the function of uNK cells.  
There are many competing hypotheses. uNK cells could be the result of pbNK cells 
trafficking into the uterus or the result of proliferation and differentiation of uNK cells 
already resident in the endometrium. uNK cells may cause the endometrium of RM 
patients to become hostile to the invading trophoblast. Or uNK cells could make the 
endometrium of RM patients more receptive which may lead to the implantation of 
abnormal fertilised foetuses which subsequently miscarry. 
It is already well-known that endometrial uNK cells are important for the 
establishment of pregnancy and alterations in the uNK cell population are associated 
with early pregnancy failure. However a causal link remains to be established and 
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further studies are needed to determine the precise role of uNK cells in the 
endometrium of RM patients.   
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1.5.1 IMPORTANCE OF CONDUCTING THIS RESEARCH 
 
Much of the present research surrounds how uNK cells can act in a way that is harmful 
to the foetus resulting in miscarriage.  Therefore, prediction of uNK cell function and 
its therapeutic development are desirable and a potential revenue generating goals. 
This desire to know whether uNK manipulation could elevate success rates for RM 
patients is mesmerising. Interest in uNK cells does not end with successful pregnancy 
outcome since intrauterine programming has continuing consequences on the 
offspring. The entire next generation will benefit from a greater understanding of uNK 
cell function.  
Not only is this research beneficial to humans, therapeutic manipulation of uNK cells 
also interests livestock producers. They desire a more economic production by 
increasing offspring numbers and gestational success of unique, high cost or 
genetically modified embryos.  
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1.6 - HYPOTHESIS 
 
The hypothesis for the following research is that the uNK cells in patients with RM will 
show evidence of proliferation and differentiation of resident uNK cells but not 
trafficking of pbNK cells. This will be determined using various uNK cell markers for 
proliferation; KI67, differentiation; NKp30 and trafficking; CD16 and L-Selectin. 
 
1.6.1 AIM 
 
This hypothesis will be tested using Immunohistochemical staining of endometrial 
tissue received from RM patients of extreme phenotype between LH + 7-9 days will 
allow us to determine the role of uNK cells by looking at their numbers in different 
locations, the epithelial edge, areas of low stromal cell density and peri-vascular 
stroma. The universal NK cell marker, CD56 will be used to identify uNK cells in the 
endometrium. The research will determine whether uNK cells may play a part in spiral 
artery remodelling and trophoblast invasion.  
 
In addition, the results will be compared and contrasted for the occurrence of these 
marker in the endometrial tissue of RM patients already identified as having a ‘high’ or 
‘low’ density of uNK cells. 
 
The hypothesis will be acknowledged as correct if the majority of uNK cells stain 
positive for ki67 and NKp30 and very few stain positive for L-Selectin or CD16. 
Furthermore in cases with high density of uNK cells there will be more positively 
stained cells for KI67. If uNK cells that surround the blood vessel in the endometrium 
are highly positive for L- Selectin and CD16 then we can say that the uNK cells may 
result from trafficking of pbNK cells. However, if uNK cells stain highly positive for 
NKp30 and KI67 and not so much for L-Selectin and CD16 then we can say that uNK 
cells may proliferate and differentiate from resident uNK cells.  
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CHAPTER 2 – METHODS 
 
 
Fig 2: Schematic diagram representing an overview of the method from the tissue sampling to image analysis 
 
Endometrial Biopsy Tissue Fixation
Tissue Processing
Embedding tissue in 
Paraffin
Sequential Section 
Cutting
Antigen Retrieval
Immunohistochemistry Photographing
Image Analyis
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2.1 PATIENT SELECTION 
 
From a database of an ongoing study of a larger population of female patients (N = 
500), 20 recurrent miscarriage patients (≥ 3 consecutive miscarriages) of extreme 
phenotype were selected. They were recruited from throughout the UK via referrals 
from general practitioners or local hospital consultants. 10 patients were grouped as 
high uNK, defined as an uNK cell density value of ≥ 5% (131) and 10 were grouped as 
low uNK, defined as an uNK cell density value of ≤ 2.5%. The low cut off point was 
chosen at this level because it will allow comparisons to be made with those in the 
high group. It is a pragmatic way of having a demarcated difference between the two 
groups. Anything lower would make it difficult to count the cells reliably. Only those 
women who had a regular 28 day menstrual cycle were included. This then excluded all 
peri-menopausal women. Women were also excluded if they tested positive for any of 
the following possible contributing factors for pregnancy loss; antiphospholipid 
syndrome, thrombophilia, uterine anomaly, polycystic ovarian syndrome, diabetes, 
abnormal thyroid function tests or parental balanced translocations.   
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2.2 ENDOMETRIAL SAMPLING  
 
All women used a commercially available urine LH kit to confirm the mid-cycle urinary 
LH surge. They then rang the hospital to arrange for an endometrial biopsy 7-9 days 
after the LH surge. At sample collection all women had a transvaginal scan to ensure 
normal endometrial thickness. The samples were obtained using a pipelle sampler to 
attain an endometrial biopsy. All women had given written informed consent for an 
endometrial biopsy and a chaperone was present at all times.  
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2.3 ENDOMETRIAL BIOPSY RECEPTION 
 
The fixation of endometrial biopsy samples in 10% neutral buffered formalin (NBF) was 
carried out as described below. Laboratory coats and nitrile gloves were worn at all 
times when handling the unfixed biopsies. All manipulations on the fresh samples were 
performed in the class II microbiological safety cabinet.  
 
Equipment Information: 
 Dry ice, Virkon and laboratory plastics (e.g. universals etc) are purchased from 
Liverpool Women’s Hospital (NHS) purchasing department.  
 Nunc cryotubes are purchased from Corning.  Distributor address: PO Box 75089, 
1117 ZP Schiphol, Koolhavenlaan, The Netherlands. 
 Forceps and scissors are supplied by Raymond A Lamb Ltd. Manufacturer’s 
address: Units 4 & 5, Parkview industrial estate, Eastbourne, East Sussex, BN23 
6QE England. 
 TriGene Advance is obtained from Medichem International. Supplier address: PO 
Box 237, Seven Oaks, Kent, TN15 0ZJ. Telephone: 01732 763555. 
 Neutral Buffered Formalin solution is purchased from Sigma Aldrich. Supplier 
address: Fancy road, Poole, Dorset, BH12 4QH. Telephone 01202 712300. 
 Biomat2 Recirculating microbiological safety cabinet was purchased from 
Bioquell. Supplier information: Walworth road, Andover, Hampshire, SP10 5AA. 
 
Firstly the lab was prepared to receive the endometrial biopsy. This was done by 
cleaning the surfaces of the microbiological safety class II (MCII) cabinet with 1% 
TriGene Advance solution and dried with absorbent towels. The following items were 
collected and placed on a clean plastic tray in the MCII cabinet: Universal tube 
containing 4% neutral buffered formalin (NBF), which was labelled with the date and 
the patient number, small weighing boats, forceps and scissors, discard pot containing 
1% Virkon solution, equipment decontamination container (small plastic container 
filled to approximately 50% capacity with 2% TriGene Advance Solution, small bottle of 
sterile PBS, a box of dry ice and liquid nitrogen. A Nunc cryotube was then labelled 
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with the patient number and the date. The labelled cryotube and a clean pair of 
forceps were then placed in the box of dry ice to cool. 
 
The biopsy specimen was collected in a Wallach endometrial sampler and delivered to 
the class II laboratory in a transport box. The sample was then transferred to the MCII 
cabinet.  The end of the endometrial sampler was cut and the biopsy pushed out onto 
a weighing boat. The endometrial sampler was then filled with 1% Virkon and left for 
approximately 10 minutes to decontaminate, then discarded in the clinical waste 
sharps bin. In cases where a large amount of blood was present the tissue was then 
immersed in sterile PBS. Mucous and blood clots were removed from the tissue and 
placed in the 1% Virkon discard pot. The tissue was then placed into a labelled 
Universal tube (containing 4% NBF) and stored overnight in a fume cabinet. If the 
sample was collected on a Friday then the NBF pot was stored in the fridge to minimise 
evaporation. 
 
If a large sample was collected then frozen blocks were also prepared. The tissue was 
cut into appropriate lengths and half was placed into the labelled NBF pot, whilst the 
remaining was transferred onto a fresh weighing boat. The sample was then 
manipulated so that it coiled into a ‘Danish pastry’ shape. The weighing boat then was 
carefully placed to float on the surface of the liquid nitrogen using long forceps. 
Freezing occurred within a couple of seconds, the weighing boat was then removed 
from the liquid nitrogen using long forceps and placed immediately onto dry ice. It is 
then transferred into the labelled cryotube using the pre-cooled forceps.  
 
The cryotube was then placed in the storage boxes in the freezer. This information was 
all logged in a patient specimen freezer file.   The patient and sample information was 
then also entered into the lab samples database and the patient progress log updated 
with the specimen code and the collection date.  
 
The plastic weighing boats and any waste tissue was placed into a discard jar 
containing 1% Virkon. Items placed in discard jars were completely submerged and 
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incubated for at least 1 hour to ensure effective decontamination. The contents of the 
discard jar were then washed down a sink through a sieve, colander or filter paper. The 
disinfected solids then were placed into the hospital clinical waste bags for disposal.  
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2.4 TISSUE PROCESSING 
 
The formalin fixed tissue was firstly dehydrated, cleared then impregnated with 
paraffin wax using the automated Shandon Citadel 1000 processing machine. The total 
processing time was 18 ¾ hours. The processing schedule was made up of: 45 minutes 
in 4% formalin in neutral buffer, 1 hour in 60% Ethanol, 1 hour in 70% Ethanol, 1 hour 
in 90% Ethanol, 1 hour in 100% Ethanol 1, 1 ½ hours in 100% Ethanol 2, 2 hours in 
100% Ethanol 3, 1 hour in Xylene 1, 1 ½ hours in Xylene 2, 2 hours in Xylene 3, 2 ½ 
hours in Wax 1 and 3 ½ hours in Wax 2. 
 
Equipment information: 
 
 Citadel processor manufacturer: Thermo electron Corporation. Manufacturer’s 
address: Chadwick Road, Astmoor, Runcorn, Cheshire, WA7 1PR England. 
 Ethanol and xylene are purchased from Chemistry solvent stores (University of 
Liverpool).  
 The wax (Paramat Paraplast Gurr) and the neutral buffered formalin are 
purchased from VWR International Ltd (UK). VWR address: Hunter Boulevard, 
Magna Park, Lutterworth, Leicester, England, LE17 4XN 
 
Between processing runs, the ethanol solutions were stored in labelled bottles to 
prevent evaporation. Therefore the solvent containers were re-filled before tissue 
processing. Firstly, plastic cassettes were labelled with the sample ID number using 
pencil. The tissue was then removed from the formalin pot using forceps and placed 
into small wire inserts, which were secured into the plastic cassettes and the sample ID 
was re-checked once more. This was all done in the fume hood. The used formalin was 
then disposed of in a solvent waste can. The cassettes were loosely spaced in the 
processing baskets which were then lowered into formalin. The following method was 
used as shown in table 4. 
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Date of 
Processing 
Processing 
Time 
Hand Held Controller Action 
Monday-Thursday Before 2pm Press delay on button 
Monday-Thursday After 2pm Press autostart button 
Friday Before 2pm Press days delay, scroll to 2 days using the + button then press 
delay on. 
Friday After 2pm press days delay, scroll to 1 day using the + button, then press 
delay on 
 
Table 4: Highlights the processing schedule dependent on which day and time the samples were put it in 
the processor.  
     
Once the processing cycles were completed, the samples were embedded using the 
embedding machine. 
 
The solvents were changed on a regular basis to ensure efficient processing of the 
tissue samples. Waste solvents were placed in red solvent waste containers and 
identified clearly with the appropriate labels. Contaminated waste wax was discarded 
by pouring the molten solution into a container and cooling until the wax was set. The 
wax container was then disposed of in clinical waste.  
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2.5 TISSUE EMBEDDING 
 
The Shandon Histocentre 3 embedding machine was used to embed endometrial 
tissue samples after they had been processed as mentioned previously. This was done 
in the following way: the cassettes removed from the holder in the processor ensuring 
that wax does not drip on the floor. The block then placed into the heated reservoir in 
the embedding machine. Absorbent towels used to remove surplus wax from the 
cassette and placed into the oven (heated to ~100°C) for several minutes to remove 
any residue. A metal mould from the heated unit was then placed underneath the wax 
tap and half-filled with wax. The cassette was then placed on the heated area near the 
wax tap to prevent solidification of the wax. The cassette was then opened and the 
sample transferred to the wax-filled mould using hot forceps. The mould was then 
placed on the “cold spot” at the front of the dispensing unit and hot forceps used to 
position the tissue in the mould at the bottom. The sample was then covered with a 
plastic cassette which was numbered accordingly. The wax was topped up and placed 
on a pre-cooled cooling block to set. After ~30 minutes the cassette came cleanly away 
from the metal mould, if necessary forceps or a scalpel was used to loosen the edges. 
The block was then stored in metal storage cabinets in numerical order ready to be 
cut. The metal biopsy inserts were placed in Xylene to clean off any remaining wax 
ready for re-use.  
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2.6 CUTTING 
 
Equipment Information: 
 Micron HM335 rotary microtome is supplied by MICROM Company. 
Manufacturer’s address: Microm UK Ltd, 8 Thame Park Business Centre, 
Leinman Road, Thame, OX9 3XA. http://www.micron-online.com 
 Microscope slides (super premium twin frost, catalogue number 631-0111) are 
purchased from VWR International. UK based distributor is located at: Hunter 
Boulevard, Magna Park, Lutterworth, Leicestershire, LE17 4XN.  
 Microtome blades (feather, stainless steel S35) are purchased from Liverpool 
Women’s Hospital (NHS) purchasing department.  
 Forceps, paintbrush, section dryer and water bath are supplied by Raymond A 
Lamb Ltd. Manufacturer’s address; Units 4 & 5, Parkview industrial estate, 
Eastbourne, East Sussex, BN23 6QE England.  
  
The water bath was first filled with distilled water and set to approximately 40oC. The 
sample block to be cut was placed in the fridge 30 minutes prior to use. The blade 
angle was pre-set to 10-12o. This setting ensured minimal amount of tissue was wasted 
when many sections were prepared from the same block. A new block was set to trim 
at 10-20μm until a representative amount of tissue was exposed in the tissue block. 
The section thickness was then set between 3-5μm. All the sections used in this study 
were cut at 4μm. After the first section was cut, using forceps the end was gently held 
onto whilst cutting continued to produce a ribbon of 8 or more sequential sections. 
The sections were then carefully placed to float onto the water in the pre-warmed 
water bath. The sections were separated gently using the pressure of forceps. They 
then were floated onto APES coated slides (3-aminopropyltriethoxysilane, Sigma 
Chemical Co, Poole, UK) in order of when they were cut. Each section was placed onto 
the slide in the same orientation as the previous one. The frosted part of the slide was 
labelled with the specimen ID and thickness (using a pencil). The slides were then 
placed in a rack to dry at room temperature overnight. They were then ready to be 
baked as required for the immunohistochemical staining procedure.  
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2.7 STAINING 
 
The endometrial tissue was stained using immunohistochemistry, with antibodies to 
CD56, KI67, NKp30, L-Selectin and CD16. They are uNK cell markers of proliferation, 
differentiation and migration/trafficking respectively.  
Immunohistochemistry is the process of localising antigens (e.g. proteins) in cells of a 
tissue section. This is done by the use of labelled antibodies as specific reagents 
through antigen-antibody interactions that are then visualised by a marker such as 
fluorescent dye, enzyme, or colloidal gold (170).  
Tissue preparation is the foundation of immunohistochemistry. For this reason the 
endometrial tissue sample is prepared initially to ensure preservation of architecture 
and cell morphology. This is achieved by prompt and adequate fixation of the sample 
in 10% NBF. Inadequate or prolonged fixation can reduce the antibody binding capability 
to a great extent. Formalin-fixation and paraffin-embedding is widely used in routine 
immunohistochemistry. However, certain antigens are not capable of surviving this 
technique and the tissue has to be frozen. The disadvantages of frozen sections are 
poor morphology, poor resolution at higher magnifications and cutting difficulty over 
paraffin sections (170).  
The expression of the antigen can be also be improved by the pre-treatment of the 
tissue sample with an antigen retrieval reagent such as citrate buffer solution. Antigen 
retrieval is carried out in a pressure cooker to allow breakage of the protein cross-links 
formed by the earlier fixation in formalin and thus uncover the hidden antigen sites 
(170). 
The antibodies used for specific detection are either polyclonal or monoclonal. 
Monoclonal antibodies are generally considered to display greater specificity. 
Antibodies can also be classified as primary or secondary reagents. Primary antibodies 
are raised against an antigen of interest and are unconjugated (unlabelled), whilst the 
secondary antibodies are raised against the primary antibodies. Also, secondary 
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antibodies recognise immunoglobulins of a particular species and are conjugated to a 
reporter enzyme such as horseradish peroxidase (HRP). 
There are two methods used for the detection of antigens in tissues, the direct method 
and the indirect method. We used the indirect method within which an unlabelled 
primary antibody (first layer) reacts with the tissue antigen and a labelled secondary 
antibody (second layer) then reacts with the primary antibody. The second layer 
antibody is then labelled with an enzyme and reacted with DAB to produce a brown 
staining wherever primary and secondary antibodies are attached (170). 
The staining protocol overall is:   
i) Application of a primary antibody 
ii) Application of enzyme labelled polymer, a secondary antibody  
iii) Application of the substrate chromagen (DAB). 
 
The antibodies were validated using various different concentrations to find the most 
optimal staining for the endometrial tissue. This is highlighted in table 5 on the next 
page. For each validated staining run tonsil was used as a positive control, since it has 
already been validated to stain extremely well for CD56+ NK cells.  
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Validation of antibody concentration: 
Antigen 
Antibody 
/cat# 
Clone Polymer Company Dilution Duration 
Ki67 
NCL-Ki67-
MM1 
MM1 Mouse Novocastra 
1:100, 1:150, 
1:200, 1:400 
60 mins 
CD56 
NCL-L-
CD56-1B6 
1B6 Mouse Novocastra 1:50 60 mins 
CD16 DJ13OC VlFcRlll Mouse Dako 
1:50, 1:100, 
1:200 
60 mins 
CD62-L 
AB49508-
500 
9H6 Mouse Abcam 
1:25, 1:50, 
1:100 
60 mins 
NKp30 SC-20477 SC-20477 Goat Santa Cruz 
1:100, 1:200, 
1:400 
60 mins 
Mouse 
IgG  
MCA928 IgG1 Mouse Serotech 1:100 60 mins 
Goat IgG  Sc-2028 Sc-2028 Goat Santa Cruz 1:200 60 mins 
 
Working Dilutions used: 
Antigen 
Antibody 
/cat# 
Clone Polymer Company Dilution Duration 
Ki67 
NCL-Ki67-
MM1 
MM1 Mouse Novocastra 1:150 60 mins 
CD56 
NCL-L-
CD56-1B6 
1B6 Mouse Novocastra 1:50 60 mins 
CD16 DJ13OC VlFcRlll Mouse Dako 1:100 60 mins 
CD62-L 
AB49508-
500 
9H6 Mouse Abcam 1:25 60 mins 
NKp30 SC-20477 Polyclonal Goat Santa Cruz 1:100 60 mins 
Mouse 
IgG  
MCA928 IgG1 Mouse Serotech 1:100 60 mins 
Goat 
IgG  
Sc-2028 sc-2028 Goat Santa Cruz 1:200 60 mins 
 
Detection Information: 
Detection Kit Kit /cat# Company Dilution Duration 
DAB EnVision  K4006 Dako 1:50 10 mins 
Dako (anti-
mouse) 
K4003 Dako 1 Drop 30 mins 
Vector 
ImmPress Kit 
(anti-goat) 
MP-7405 Vector Labs 1 Drop 30 mins 
 
 
Table 5: Details of all solutions used in the study 
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Prior to carrying out the staining, the slides with the samples to be stained were baked 
in an oven at 37ºC overnight. The following day they were put through a set of 
solutions to remove as much wax off the sample as possible. This was done by 
incubating the samples in 2 changes of xylene for 10 minutes, 2 changes of absolute 
ethanol for 3 minutes each, 90% ethanol for 1 minute and 70% ethanol for 1 minute 
prior to transfer into water. The slides then underwent antigen retrieval as they are 
placed in a pressure cooker containing citrate buffer solution made up of 3.15g of citric 
acid, 1.5L dH2O at pH 6 for 1 minute. 
 
The slides were then placed in a staining dish containing Tris Buffered Saline solution 
(TBS) and incubated for 5 minutes at room temperature. Endogenous peroxidise 
activity was blocked by incubating the slides in 0.3% H2O2 for 10 minutes at room 
temperature. Humidifying chambers were prepared by placing folded paper towels in 
the centre gulleys and soaking them with distilled water. The slides were washed twice 
more with TBS for 5 minutes at room temperature each time. Area to be stained was 
marked with a DAKO hydrophobic marker pen ensuring that the tissue was surrounded 
with sufficient space to allow spreading of the antibodies. Antibody diluent made up of 
TBS and 0.5 % BSA was prepared in the following ratio (e.g. 250 µl 10% BSA + 4750 µl 
TBS). Working dilutions of each antibody were also prepared allowing 50 µl per 
section. The slides were then placed in the humidifying chamber and 50µl of the 
appropriate antibody to each section was applied, which was spread using parafilm to 
ensure the entire section was covered. The slides were then left to incubate for 60 
minutes at room temperature.  
 
The slides were then tapped off and placed in a staining dish filled with TBS for 5 
minutes at room temperature. The TBS was decanted and refilled and incubated for 
another 5 minutes. The slides were then returned to the humidifying chamber and a 
drop of mouse or goat polymer-HRP applied accordingly, ensuring the entire section 
was covered using parafilm. The slides were then incubated further for 30 minutes at 
room temperature. The slides again were tapped off and incubated in TBS twice for 5 
minutes each time. 
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DAB (3, 3-diaminobenzidine), a substrate and chromagen solution, was prepared using 
the following ratio, also allowing for 50 µl per section: 20µl/1000µl substrate. The 
slides were returned to the humidifying chamber and the substrate and chromagen 
solution was applied and spread using parafilm on each section. They were left to 
incubate for 10 minutes. The slides were then immersed immediately in tap water to 
stop the reaction. 
 
The endometrial samples were lastly counterstained using filtered Gill 2 haematoxylin 
for 2 minutes, and were then immersed in tap water and rinsed until the water ran 
clear. First, they were briefly dipped in acid alcohol to remove the background 
haematoxylin, and then immediately back into tap water for 5 minutes, The slides then 
underwent the following set of solutions to dehydrate the sample: 1 minute in 70% 
ethanol, incubated for 1 minute in 90% ethanol, incubated for 3 minutes in 100% 
ethanol1 and then 2, incubated for 5 minutes in Xylene 1 and incubated for 10 min in 
Xylene 2. Sufficient DPX was applied to cover all the section and a coverslip was 
applied over each. Air bubbles were removed and the slides left to dry overnight in the 
fume hood.  
 
Appropriate positive controls were also stained with each staining run to confirm 
staining, and negative controls were stained for each sample by replacing the primary 
antibody with mouse or goat IgG.  
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2.8 PHOTOGRAPHING 
 
All 20 RM women had their endometrial samples photographed for epithelial edge, 
areas of low stromal cell density, also known as oedema and peri-vascular areas. First 
for each RM patient, the whole tissue was glanced at under the microscope, to 
appreciate what the remaining tissue was like, whether it remained on the slide, 
whether it was inconsistent and therefore cannot be photographed.  All the slides for 
the RM patient were first looked at in this way, before sequential photographs were 
taken.  
 
A photographing log was kept of all the slides, staining and photographing. When the 
tissue was first looked at under the microscope, a drawing by hand was made of the 
outline of the tissue. Areas of the tissue that were inconsistent were noted down for 
future reference. Other comments were also noted to help identify the tissue, for 
example if the staining was weak or there was a particular pattern of staining for a 
certain antibody; e.g. more staining around vessels, was all noted.  
 
Sequential micrographs were then produced for each RM. Three areas of epithelium, 
three areas of low stromal cell density and three areas of per-vascular areas, all images 
had glands in them, they were used as reference points when trying to find the same 
location on the next sequential section. As seen in table 6, the order of the antibodies 
listed are the same as how the sequential sections were stained. For every antibody 
either side, a CD56 in the middle was stained. This was so a comparison could be made 
with the CD56 stained sections.  
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RM Number... 
 Location 
Antibody 
Epithelial Edge 
x3 
Low stromal cell density 
x3 
Spiral arteries 
x3 
IgG Goat    
NKp30    
CD56    
KI67    
CD16    
CD56    
CD62-L    
IgG Mouse    
 
Table 6: An example of the photographing log used to record the information about the sections once 
looked at under the microscope. 
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2.9 IMAGE ANALYSIS 
 
uNK cell density was assessed using an Image analysis software. This was chosen to 
analyse micrographs because it offers the benefit of reducing inter-observer variability. 
This method was previously validated by the department. There were two parts to the 
image analysis, firstly, it was to count number of stromal cells and secondly to count 
positively stained cells, with the aim to produce a percentage for each stain per 
stromal count for each micrograph, for each area to be looked at. The advantage of 
producing three micrographs per stain per location enhanced accuracy by enabling use 
of an average in the analysis of results. 
 
Equipment information: 
   
Setup 1 
 Nikon Biophot Microscope, Nikon Corporation, Tokyo 100-8331, Japan 
 Nikon DS-5M camera head 5M pixel, Nikon Corporation, Tokyo 100-8331, Japan 
 Nikon Digital Sight DS-U1 digital control unit, Nikon Corporation, Tokyo 100-8331, 
Japan 
 Nikon C-Mount TV adaptor 0.6x, Nikon Corporation, Tokyo 100-8331, Japan 
 Eclipsenet software, developed by Laboratory Imaging s.r.o. for Nikon Instruments 
Europe B.V., 1170AE Badhoevedorp, The Netherlands       
 Adobe Photoshop CS2 software, Education Version.  Adobe Systems Incorporated. 
345 Park Avenue, San Jose, CA 95110-2704 USA www.adobe.com 
 
Setup 2 (supplied by Jencons-PLS) 
 
 Nikon Eclipse 50i Microscope, Nikon Corporation, Tokyo 100-8331, Japan  
 Nikon DS-Fi1 digital camera Head 5M pixel, Nikon Corporation, Tokyo 100-8331, 
Japan 
 Nikon Digital control unit DS-U2 USB, Nikon Corporation, Tokyo 100-8331, Japan 
 Nikon C-Mount TV adaptor, 0.63x, Nikon Corporation, Tokyo 100-8331, Japan 
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 NIS-Elements-F software, developed for Nikon Instruments  
 Adobe Photoshop CS3 software, Education Version.  Adobe Systems Incorporated. 
345 Park Avenue, San Jose, CA 95110-2704 USA www.adobe.com 
 
Both systems 
 Personal computer (minimum specification 1GB RAM, 2.8GHz processor) 
 WCIF Image J     http://www.uhnresearch.ca/facilities/wcif/fdownload.html  
 
Nine digital images; 3 of epithelial edge, 3 of low stromal density and 3 of endometrial 
peri-vascular areas at high power (x400) fields were captured on either setup 1 or 
setup 2 for each patient per antibody.  
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2.9.1 STROMAL COUNTING 
 
Adobe Photoshop was used to prepare the micrographs for image analysis. Each file to 
be analysed had every gland and vessel manually removed by using the Magic Lasso 
tool, an outline of each structure was produced then deleted. Following this, it was 
important to remove the DAB staining to just leave the blue stained stromal cells. This 
was achieved by using the Magic wand tool, to select and delete areas of ‘brown’ 
positive staining. At each step images were saved in TIFF format, to prevent detail 
being lost in other compression formats.  
 
A stromal cell count was obtained using Image J software. Each file with DAB removed 
(stroma images) were opened with Image J and subsequently saved as 8-bit grey scale 
images (Image|Type|8 bit). A threshold could now be applied to the image 
(Image|Adjust|Threshold) set at a level which accurately represents the majority of 
cells visible in ‘red’ without background being selected also. The threshold number was 
noted to enable adjustment at a later stage if necessary. If needed ‘smooth’ function 
was applied to smoothen the cellular edges and have more defined outlines. The 
threshold was then applied. If a significant proportion of the cells were patchy they 
were filled using Process|Binary|Fill. Cells were separated using the watershed 
function (Process|Binary|Watershed) to enable distinct cells to be counted, instead of 
a cluster. To count the number of nuclei, the analyse particles function was used 
(Analyse|Analyse Particles) with the following settings (Setup 1 Size: 0.0015-0.1, Setup 
2 Size: 36-2250, with both setups using the following:  Circularity: 0.3-1, Show outline, 
Clear results, Summarise). An outline of the nuclei was then displayed. This image was 
then inverted and merged with the original. The cells were visually checked to see 
whether the outlines match with the cell nuclei of the original picture and that the 
clusters of cells are split and identified appropriately. A summary box of the total cell 
count was produced. This number was noted down. 
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2.9.2 POSITIVELY STAINED CELL COUNTING 
 
Image J software was used for the identification of positively stained cells. Each 
original file was opened and the positively stained cells counted using the ‘point picker’ 
tool (Plugins|Particle Analysis|Pointpicker), after applying a grid to make counting 
easier and more accurate (Plugins|Particle Analysis|Grid Average per point = 15170, 
pixel width = 2). For the nucleus markers, NKp30 and Ki67, the positively stained cells 
were identified as those in which there was a brown stained nucleus instead of the 
haematoxylin stained blue stromal nuclei. As for the cytoplasmic markers CD56, CD16 
and CD62-L/L-Selectin positively stained cells were those which contain a blue stained 
nuclei surrounded by brown DAB staining to these antibodies.  Positively identified 
cells were marked with a cross. Markers could be removed and moved by selecting 
corresponding buttons on the menu bar. When all positively stained cells had been 
identified, a results box was obtained by selecting ‘show’ on the menu bar. The total 
number of cells identified was noted.  
 
To obtain a percentage of stromal cells stained the stained cell count was divided by 
the total stromal count and multiplied by 100.  
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2.10 UNK CELL COUNTING VALIDATION 
 
A selection of micrographs were counted and identified as the ones used for 
validation. A number of micrographs of patients were counted by me, uNK and stromal 
counts. These patients had already been counted by those who have already been 
validated to count in the department. The counts were then compared against their 
counts and a Bland-Altman graph was produced. The counting process was repeated 
until our differences were very small.  
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2.11 STATISTICAL METHODS USED FOR RESULTS ANALYSIS 
 
SPSS version 16 was used for all statistical analyses. Each condition was measured 
more than once for each individual, varying from 2 replicates per condition to 9 
replicates per condition. The mean value for each condition for each individual was 
used in the analysis. The first step in analysis was to summarise the demographic 
characeteristics of the participants. Then, the possibility of an association between age 
and uNK cell density was explored using correlation analysis. The measurements of 
uNK cell density made by me were compared to measurements made by other 
workers in the lab. Bland-Altman plots were used to check whether there were any 
systematic differences between experienced cell counters, myself and a colleague. 
Typical examples of immunohistochemical staining were prepared.  
 
The next step in analysis was to express the expression for each antibody at each 
location in graphical format, grouping by uNK cell density status.  The interpretation of 
the graphical analysis was supplemented using Analysis of Variance. Each woman 
contributed data for each antibody in three conditions. This meant that there was an 
element of repeated measurement. As a pragmatic measure to overcome any effects 
of repeated measurements, study patient number was used as a covariate. Post hoc 
tests are not possible with a covariate. Accordingly, a simple contrast was used to 
compare the locations, with epithelium as a reference group. An interaction term to 
examine whether differences in location differed according to uNK cell density status 
was also included. This interaction term was not significant in any of the analyses and 
so is not presented in the results. 
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CHAPTER 3 - RESULTS 
 
Maternal age at conception and previous reproductive history are strong and 
independent risk factors for miscarriage. The chance of a successful pregnancy in a 
woman aged 40 years or more is poor. 
 
 
Fig 3: A graph demonstrating the relationship between age of women with RM and their uNK results 
 
 
Figure 3 demonstrates the relationship between maternal age of RM patients and uNK 
cell level. The correlation coefficient (R2) of 0.0063 indicates the strength and direction 
of the linear relationship between maternal age and uNK cell level. The degree of 
correlation is so diminutive that the relationship is nonexistent. Therefore this does 
not interfere as a confounding factor with the analysis of the results.  
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3.1 DEMOGRAPHIC DETAILS OF WOMEN INCLUDED IN STUDY 
 
 HIGH UNK CELL DENSITY 
(N=10) 
MEDIAN (RANGE) 
LOW UNK CELL DENSITY 
(N=10) 
MEDIAN (RANGE) 
UNK (%) 8.1 (5.2-13.8) 1.95 (1-2.4) 
AGE (YEARS) 37 (32-44) 36 (31-44) 
FIRST TRIMESTER 6 (5-7) 7 (5-17) 
SECOND TRIMESTER 0 (0-3) 0 
STILL BIRTH 0 (0-1) 0 
LIVE BIRTH 0 (0-5) 0 (0-1) 
ECTOPIC PREGNANCY 0 0 
 
Table 7: The demographics of the patients included in the study 
 
As seen in table 7, the median age is very similar for both high and low uNK cell density 
groups. This is also similar for the number of miscarriages for all women. The patients 
in the two groups were matched as closely as possible, in terms of age, number of 
miscarriages, as shown above, to try and minimise any confounding variables.  
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3.2 UNK CELL COUNTING VALIDATION 
 
A Bland-Altman plot is a statistical method used to compare two measurement 
techniques, in this case the number of uNK cells counted.  The differences between the 
two counts are plotted against the averages of the two counts. Horizontal lines are 
drawn at the mean difference and at the limits of agreement, which are defined as the 
mean difference plus and minus 1.96 times the standard deviation of the differences. 
This was produced to analyse the similarity between me and others in the department 
who have already been validated previously. The same parameter is measured and a 
correlation is produced. This is demonstrated in Figure 4 on the following page.  
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Fig 4: The graphs display a scatter diagram of the differences plotted against the averages of the two 
measurements, AT vs. AK, JD vs. AK, AK vs. LK. Horizontal lines are drawn at the mean difference, and at the limits of 
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agreement, which are defined as the mean difference plus and minus 1.96 times the standard deviation of the 
differences. 
3.3 MICROGRAPHS OF LOW UNK CELL DENSITY RM PATIENTS 
 
3.3.1 EPITHELIAL EDGE 
 
     
     
     
 
 
Fig 5: Example of Epithelial Edge staining for a low uNK Cell density patient, A-CD16, B-CD56, C-KI67, D-
NKp30, E-CD62-L, F-IgG Goat 
 
A B 
C D 
E F 
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    3.3.2 LOW STROMAL CELL DENSITY/OEDEMA 
 
     
     
     
 
 
Fig 6: Example of Low stromal cell density/oedema staining for a low uNK Cell density patient, A-CD16, 
B-CD56, C-KI67, D-NKp30, E-CD62-L, F-IgG Goat 
  
D 
A B 
C D 
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3.3.3 SPIRAL ARTERIES 
     
     
        
 
Fig 7: Example of stromal staining around spiral arteries for a low uNK Cell density patient, A-CD16, B-
CD56, C-KI67, D-NKp30, E-CD62-L, F-IgG Mouse 
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3.4 MICROGRAPHS OF HIGH UNK CELL DENSITY RM PATIENTS 
 
3.4.1 EPITHELIAL EDGE 
      
     
     
  
 
Fig 8: Example of stromal staining near epithelial edge for a high uNK Cell density patient, A-CD16, B-
CD56, C-KI67, D-NKp30, E-CD62-L, F-IgG Mouse 
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3.4.2 LOW STROMAL CELL DENSITY/OEDEMA 
     
     
     
   
Fig 9: Example of stromal staining in low stromal cell density/oedema areas for a high uNK Cell density 
patient, A-CD16, B-CD56, C-KI67, D-NKp30, E-CD62-L, F-IgG Mouse  
A B 
C D 
E F 
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3.4.3 SPIRAL ARTERIES 
 
     
     
     
 
 
Fig 10: Example of stromal in a peri-vascular area for a high uNK Cell density patient, A-CD16, B-CD56, C-
KI67, D-NKp30, E-CD62-L, F-IgG Mouse 
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3.5 GRAPHS 
 
 
 
Figure 11: Graph illustrating the number of antibody Stained cells  
in the two uNK Cell Density groups 
 
Figure 11 highlights the difference between the high and low uNK cell density groups 
and how they differ for all the stained antibodies. The high uNK cell density group has 
much higher numbers of stained uNK cells compared to low for all antibodies stained.  
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Figure 12: Graph illustrating the difference in location of CD56+ uNK cells  
in the two uNK cell density groups 
 
Figure 12 above highlights the difference between the high and low uNK cell density 
groups and how they differ for all three locations. The high uNK cell density group has 
much higher numbers of uNK cells compared to low, this is as expected and can be 
seen in all three areas. The difference between the two groups at each location is 
statistically significant because the standard error bars show no overlap between the 
two groups for each location. 
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Figure 13: Graph illustrating the difference in antibody stained per location 
 in the low uNK cell density group 
 
Figure 13 shows how the Unk cell numbers vary for each antibody stained in each of 
the three locations for the low Unk cell density group. As seen from the graph there is 
great variation between all the antibodies at each location. Generally, the number of 
positive cells stained for the antibodies are seen highest around vessels.  
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Figure 14: Graph illustrating the difference in antibody stained per location  
in the high uNK cell density group  
 
Figure 14 shows how the uNK cell numbers differ for each antibody stained in each of 
the three locations for the high uNK cell density group. As seen from the graph there is 
large variation between all the antibodies for each location. However not all of these 
are significantly different since the standard error bars overlap to a great extent. This is 
explored in more detail later. Although, for the high uNK cell density group the number 
of cells stained for each antibody also seems to be higher around vessels, similar to 
that of the low uNK cell density group.  
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3.6 OVERALL RESULTS  
 
Antibody 
Stained 
High/Low Location 
Overall  % 
mean 
difference  
(95% CI) 
% 
significant 
difference 
Overall 
significant 
difference 
Location 
comparison 
Mean 
difference 
(95% CI) 
Significance 
of 
difference 
CD16 
1.556 
(0.933-2.179) 
P<0.0001 NS 
Oedema Vs. 
Epithelium 
0.531 
(-0.212-1.275) 
NS 
Vessel Vs. 
Epithelium 
0.817 
(0.073-1.561) 
P=0.032 
L-
Selectin 
(CD62-L) 
0.035 
(-0.034-0.104) 
NS NS 
Oedema Vs. 
Epithelium 
0.085 
(0.002-0.167) 
P=0.044 
Vessel Vs. 
Epithelium 
0.061 
(-0.021-0.144) 
NS 
CD56 
4.591 
(2.470-6.712) 
P<0.0001 P=0.055 
Oedema Vs. 
Epithelium 
0.77 
(-1.761-3.302) 
NS 
Vessel Vs. 
Epithelium 
3.011 
(0.480-5.543) 
P=0.021 
KI67 
2.092 
(1.358-2.826) 
P<0.0001 P=0.003 
Oedema Vs. 
Epithelium 
0.643 
(-0.233-1.519) 
NS 
Vessel Vs. 
Epithelium 
1.567 
(0.691-2.443) 
P=0.001 
NKp30 
2.819 
(1.369-4.269) 
P<0.0001 P=0.008 
Oedema Vs. 
Epithelium 
0.335 
(-1.397-3.066) 
NS 
Vessel Vs. 
Epithelium 
2.586 
(0.855-4.318) 
P=0.004 
 
Table 8: The following table demonstrates the overall results of the study. It shows how the staining varied between 
the high and low uNK cell density groups and also location. For each antibody an analysis of variance was 
performed. The patient number was included as a covariate and locations were compared using a simple contrast 
with epithelium as a reference category. 
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3.6.1 HIGH VS. LOW UNK CELL DENSITY GROUP 
 
All the antibodies showed a significant difference between the high and low uNK cell 
density groups except CD62-L (Table 8). The difference in CD56+ between the two 
groups was as expected because of the selection criteria used in the study.  
 
3.6.2 LOCATION 
 
Table 8 shows that the staining varies significantly overall for each antibody with 
regards to location, except for CD16 and L-Selectin. However, when these results are 
looked at in further detail with regards to specific location sites the results do show 
some significance.  
 
3.6.2.1 CD16 
 
Although no significant difference is seen overall in between location sites for CD16+ 
cells, when explored in further detail, it can be seen that there is an increase in the 
number of cells stained in the peri-vascular areas when compared to areas of epithelial 
edge. This difference is statistically significant (P=0.032).  
 
3.6.2.2 L-Selectin 
 
L-Selectin also produced no statistical difference between location sites overall. 
Although, the results did show that a larger number of cells were stained positive in 
areas of low stromal density, or oedema when compared to epithelial edge. This 
difference was statistically significant (P=0.044).  
 
3.6.2.3 CD56 
 
The pattern of staining for CD56+ cells with regards to location on the whole, almost 
attains nominal significance (P= 0.055). However when looked at further, the number 
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of CD56+ cells is significantly higher in the peri-vascular areas compared to the 
epithelial edge (P=0.021). 
 
3.6.2.4 KI67 
 
KI67 was found to statistically differ across all location sites overall (P=0.003). When 
the location sites were looked at in more detail, a significant increase in the numbers 
of positively stained cells was found at the peri-vascular areas compared to epithelial 
edge (P=0.001).  
 
3.6.2.5 NKp30 
 
Positively stained cells for NKp30 also demonstrated a significant difference across the 
location sites (P=0.008). As with the previous two antibodies, this antibody also 
demonstrated a higher number of positively stained cells in the peri-vascular area 
compared to epithelial edge.  
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CHAPTER 4:  DISCUSSION 
 
Endometrial expression of markers of cell differentiation and proliferation in patients 
with unexplained RM and high and low uNK density are described in the thesis. The 
distribution of each of these cell markers was examined. This allows us to comment on 
the spatial differentiation of NK cells and the implications for function of that 
distribution. Comments are also made on whether patients with high and low uNK cell 
density are associated with markers of uNK cell trafficking. This allows us to address a 
controversial area of clinical relevance in endometrial biology. 
 
4.1 TRAFFICKING OF UNK CELLS 
 
As seen from the result graphs, the paucity of L-Selectin+ and CD16+ stained cells in 
both groups, low and high uNK cell density suggests that uNK cells are not trafficking 
from peripheral blood. These two markers are present on the majority of pbNK cells.  
This result correlates with the findings of many other studies who (171-173) found that 
the majority of uNK cell population to be CD56+ CD16-. However, there are few other 
studies that investigated L-Selectin.  Had trafficking been the reason that some women 
have a much higher uNK cell density than others then an increased density of L-
Selectin would have been expected in the peri-vascular areas. Furthermore there 
would have been more L-Selectin positive cells in the high uNK cells density group 
compared to the low uNK cell density group. Hence this lack of L-Selectin positive is an 
important negative finding that I will explain further later in this section. 
 
A significant difference was found between the high and low uNK cell density groups 
for CD16. This could be explained by the fact that there are more CD56+ cells in the 
high uNK cell density group compared to the low, and a consistent proportion of CD56 
cells were CD16+.  However, other factors could explain the increase in CD16 in the 
high density CD56 group. The CD16 antigen is not specific to NK cells; it is also found 
on the surface of neutrophils, macrophages and mast cells. These cells are found in 
many conditions associated with the endometrium, for example, endometritis which is 
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inflammation of the endometrium. However, none of the patients sampled had any 
clinical symptoms or signs of infection. CD16 was used in this project as a marker for 
pbNK cells in the endometrium given that 90% of pbNK cells are CD56+ and CD16+ 
(151,174). Seeing as a few CD16+ cells were found in the endometrial samples, it is 
therefore reasonable to assume that the majority of CD56+ uNK cells are not those 
found in the peripheral blood.  
 
Although some argue that the uNK cells in the endometrium may result from the 
minority 10% of pbNK cell population that are CD56bright+ and CD16-. Moreover, this 
tiny pbNK cell population also expresses the receptor for the adhesion molecule, L-
Selectin (150) and given that the result found is so small concerning the number of L-
Selectin+ cells in the endometrium, this implication can be ruled out.   
 
As seen from the bar graphs, L-Selectin+ cells are practically absent in the 
endometrium of patients in both the high and the low uNK cell density groups. The 
difference between the two groups although not statistically significant causes 
uncertainty to arise as to whether the staining actually worked. However, this little L-
Selectin+ staining found in the endometrium is consistent with the findings of another 
study (104). 
 
 Nevertheless, my colleague, with whom I carried out immunohistochemistry, also 
undertook a similar project. She looked at IVF patients with implantation failure and 
found an exceptional patient who had L-Selectin+ staining. This area was identified as 
lymphoid aggregate by an experienced pathologist. The positively stained cells for L-
Selectin did not represent the typical stromal appearance of the endometrium at this 
stage. This shows that it was not the staining that did not work but that the number of 
positively stained cells for L-Selectin is scarce in the endometrium at the time of 
implantation.  
 
Lymphocytes are known to migrate to areas of inflammation by using a number of 
adhesive mechanisms via a family of adhesion molecules called homing receptors. A 
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well characterised homing receptor is L-Selectin. Studies have found that L-Selectin is 
required for homing of naive T cells to lymphoid organs such as peripheral lymph 
nodes (175). L-Selectin is also known to be expressed on many other leukocytes, and 
when blocked with the L-Selectin antibody, nonspecific triggers inhibit accumulation of 
neutrophils at the site of inflammation (176) indicating that L-Selectin has more 
diverse functions than just mediating entry of T cells.  
 
Studies have proposed a three step model for lymphocyte endothelial interactions. 
The initial interaction, also known as rolling of circulating leukocytes with endothelia is 
induced by L-Selectin. The second step is that the initial binding of leukocytes brings 
the leukocytes closer to chemoattractants released from the endothelium. Upon 
binding of the chemoattractants to the appropriate receptors on the leukocytes 
certain integrins are activated. In the final step, integrins bind to their counter 
receptors on the endothelium, thus increasing the adhesion and resulting in arrest of 
the rolling of leukocytes. Leukocytes then follow cues from chemoattractants and, 
using integrins for traction control; they cross the endothelium and enter the 
appropriate tissues (177).  
 
Several studies believe expression of adhesion molecules by uNK cells in the 
endometrium could explain homing of uNK cells to the endometrium from peripheral 
blood (156-158). However the results from this study suggest that uNK cells do not 
express L-Selectin and therefore cannot support the theory that they arrive from 
trafficking of pbNK cells. Also studies by Croy et al and Van Den Heuvel et al suggest 
ovarian steroids and the LH surge enhance the adhesiveness of NK cells and therefore 
aid trafficking of the cells into the uterus via the L-Selectin mechanism (93,159). 
Although these findings were from murine studies and therefore a direct comparison 
to the human uterus cannot be made, the findings of this study do not support this 
proposition. Since endometrial samples were taken at only LH + 7-9 you would expect 
the effect of the LH surge as suggested to result in an increase in the number of L-
Selectin+ cells. However, this is not the case in the studied RM patients.  
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If the uNK cells were to enter the endometrium from peripheral blood then a peri-
vascular distribution of the number of L-Selectin+ cells stained no matter how small 
should be expected. However, the results of this study show that most of the L-
Selectin+ cells are significantly located in the oedema compared to vessels and 
epithelium.  
 
In addition, Tedder et al carried out a study to determine the role of L-Selectin 
adhesion pathway in the recruitment of leukocytes during inflammation. He found 
significant inhibition of neutrophil, lymphocyte and monocyte migration into an 
inflammatory site in L-Selectin deficient mice (178). This finding is consistent with 
previous studies (179-182). The results indicate that the neutrophils, lymphocytes and 
monocytes lacking L-Selectin are unable to exit the bloodstream effectively. This may 
imply that uNK cells lacking L-Selectin are not a result of NK cells trafficking from 
peripheral blood as maybe they are unable to exit the blood and enter the 
endometrium.  
 
On the other hand, a few studies have found that once mature naive T cells are 
exposed to antigens and are subsequently activated, they then shed their surface L-
Selectin (183-185). This may represent what is happening in the endometrium. uNK 
cells may express L-Selectin initially but then lose it once they are activated. The study 
here demonstrates that many uNK cells at this point in time are activated since the 
levels of NKp30+ cells is seen to be quite high in both the high and low uNK cell density 
groups especially when compared to CD56+ cell numbers. This may possibly suggest 
that the uNK cells may have already shed their L-Selectin. However for this theory to 
be applied it would mean uNK cells are trafficking from peripheral blood. For this 
reason other trafficking markers need to be looked at in further detail to confirm 
whether uNK cells are trafficking from the blood or arise from resident NK cells within 
the endometrium. Also the endometrium needs to be looked at during all the phases 
of the menstrual cycle and not at just one point in time to conclude further whether L-
Selectin numbers vary. 
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A study by Smolen et al. (168) suggests that the initiation of the L-Selectin cascade is 
perhaps essential to modify the uterine environment to allow for a more stable 
adhesion of the embryo to the endometrium. Therefore L-Selectin may serve as a 
possible biochemical marker of endometrial receptivity (168). This implies that L-
Selectin is a vital feature of a positive pregnancy outcome and maybe the minute 
numbers seen in this study may help explain why these women have recurrent 
miscarriages.  
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4.2 PROLIFERATION OF UNK CELLS 
 
The results of this study are consistent with the findings of previous studies in relation 
to KI67. The number of KI67+ stained cells is significantly higher in the high uNK cell 
density group compared to the low (P<0.0001). The difference also varies significantly 
across location sites (P=0.003). A significantly higher number of KI67+ cells are found at 
the peri-vascular location compared to the epithelial edge (P=0.001). This implies that 
women with an increased uNK cell density have more proliferative uNK cells that are 
more frequently found surrounding endometrial vessels. This finding together with the 
few numbers of CD16+ and L-Selectin+ cells suggests that uNK cells originate from 
resident endometrial NK cells and do not arise from peripheral blood.  
 
KI67+ uNK cells may assist with angiogenesis of uterine spiral arteries. Embryo 
implantation and early placental development occur in a relatively hypoxic 
environment of 2-3% oxygen (186,187). The placental syncytiotrophoblast undergoes a 
minor degree of oxidative stress damage when maternal blood flow initially enters the 
intervillous space, however this soon adapts to the higher oxygen levels (188). 
However inappropriate maternal blood flow to the intervillous space may be a cause of 
RM. It has already been established that uNK cells are essential for spiral artery 
remodelling (159,189). A high number of proliferating uNK cells may increase uterine 
vessel formation too early and too quickly which in turn increases uterine artery blood 
flow and subsequently initiates oxidative stress in the early developing foetus. This 
demonstrates that a balance needs to be achieved. Patients with RM may have an 
abnormally large number of proliferating uNK cells compared to those who have no 
fertility problems. However this does not provide an explanation for the low uNK cell 
density group. The endometrial pathologies of these two groups may be different and 
therefore needs to be explored further, normal KI67 uNK levels need to be defined.  
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4.3 DIFFERENTIATION OF UNK CELLS 
 
According to the results of this study, a larger number of uNK cells are active and 
differentiated in the high uNK cell density group compared to the low (P<0.0001). This 
is as expected since the numbers of CD56+ cells are higher in this group also. The 
pattern of NKp30+ uNK cells also varies across the location sites, with the highest 
numbers around vessels (P=0.004). This pattern of staining again suggests that the uNK 
cells may contribute to spiral artery transformation therefore causing the arteries to 
develop earlier than usual. This may contribute to the early increased blood flow to the 
endometrium which means there is an increased level of oxygen which results in 
oxidative stress and causes early pregnancy loss.  
 
An alternative explanation for the peri-vascular distribution of uNK cells is that the 
cells are closely associated with endometrial stromal cell decidualisation and it is in the 
peri-vascular areas that the endometrial stromal cells first undergo pre-decidual 
change in late secretory phase endometrium (190,191). 
  
However, a study by Manaster et al (91) found conflicting results. He believes uNK cells 
are negative for NKp30 receptor expression before IL-15 stimulation and therefore are 
inactive in the endometrium before conception. However there are many problems 
with this study. Firstly, flow cytometry analysis was used to determine the results. This 
method is not comparable to immunohistochemistry, which is what was used to 
conclude the results of this study. Secondly, the patients sampled in his study may not 
have been timed correctly for the phases of the menstrual cycle, since the gold 
standard criteria developed by Noyes et al (192) or the LH surge was not used to 
detect the phases. The patients were selected by ultrasound confirmation and serum 
progesterone levels. Using progesterone levels to date the endometrium is not as 
accurate as the LH surge since it covers a broader time frame which allows for more 
variability. Thirdly, an explanation for the differences in the results may be explained 
by the fact that his patient samples were given IL-15 in vitro. This may not reflect what 
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goes on in vivo; many other factors are always involved. Lastly, no statistical method 
has been used to say whether the results of the study were significant.  
 
A study by Ponnampalam et al (92) investigated the cyclical changes of NKp30 in the 
human endometrium during the menstrual cycle. Little or no immunostaining for 
NKp30+ cells were found in the proliferative phase endometrium. Although, the results 
showed NKp30+ staining in the endometrial glands and the luminal epithelium in the 
early, mid and late secretory phase endometrium. This study was the only one to 
demonstrate the presence of NKp30 staining in the endometrium epithelium. 
Conversely, the results of our study found NKp30+ cells in the stroma near the 
epithelial edge, in low stromal density areas and surrounding vessels but not in glands 
or in the epithelium. The NKp30 staining identified by Ponnampalam et al is debatable. 
The staining in the epithelium and glands may be considered as background staining, 
since the goat polymer to this antibody is known to stain background more readily 
compared to the mouse polymer.  
 
Although the findings of this study are similar concerning the levels of NKp30 found at 
the time of implantation it cannot be compared directly. The results revealed in 
Ponnampalam et al study were carried out on frozen endometrial sections. To see 
whether we could detect a similar pattern of NKp30 expression, frozen sections of a 
few of our samples were also stained for NKp30 in our study. However, we failed to 
replicate the Ponnampalam results as shown in figure 15. In our laboratory NKp30 
continued to stain frozen sections in a similar manner to that seen in the micrographs 
of paraffin sections in the previous chapter.  
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Fig 15: The micrograph above is an example of NKp30
+
 staining on a frozen endometrial section of a 
patient from the high uNK cell density group. As seen above the positively stained cells are still staining in 
a nuclear fashion. This was cut and stained by a member of our department. 
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Fig 16: The micrograph above is an example of IgG Goat staining on a frozen endometrial section from 
the same patient in the high uNK cell density group as shown on the previous page. No positive staining 
is seen. This was cut and stained by a member of our department 
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Another difference highlighted between the findings of our study and that of 
Ponnampalam et al and Manaster et al’s study is that the NKp30 staining was noticed 
to be nuclear in our data. To address this difference observed we looked at the staining 
pattern of NKp30 in termination of pregnancy samples from the first trimester decidua 
of varying gestational age (Figure 17). If in the following studies, the NKp30 positive 
peaks seen on flow cytometry were only observed once stimulated with IL-15, in vitro, 
it could be that changes from nuclear staining to cytoplasmic staining could occur as 
part of differentiation of cells. However, the decidual staining produced was not any 
different to that found in the late secretory phase endometrium in that the NKp30 
staining remained nuclear. This is illustrated by the micrographs in figure 17. From this 
we must conclude that our staining of the novel NKp30 is the first to truly be observed 
in frozen and paraffin late-secretory phase endometrial sections and first trimester 
decidua. 
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Fig 17: The micrographs above show staining on A- CD56
+
, B- NKp30
+
 a 6 week decidua. As seen the 
NKp30 is still producing nuclear staining. C- CD56
+
 staining, D- NKp30
+
staining a 7 week decidua, again 
nuclear stained cells are seen. E- CD56
+
 staining, F- NKp30
+
staining an 8 week decidua, again nuclear 
stained cells are seen. G- CD56
+
 staining, H- NKp30
+ 
staining a 10 week decidua, again nuclear stained 
cells are seen. I- CD56
+
 staining, J- NKp30
+ 
staining a 12 week decidua, again nuclear stained cells are 
seen. All the sections were cut and stained by a member of the department. 
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5 – CONCLUSIONS 
  
5.1 METHODOLOGICAL LIMITATIONS 
 
There are fundamental limitations in the methodologies used in previous studies. The 
levels and activation of NK cells is dependent on many variables, these include, 
whether whole blood or fractionated mononuclear cells are used, the time of day the 
sample is taken, whether any physical exercise has been performed prior to the biopsy, 
the parity of the patient and whether the samples have been previously frozen (193-
197). 
  
Another problem is that the number of uNK cells during a menstrual cycle change 
rapidly and the density of endometrium is not constant, therefore the results 
produced by the endometrial samples in different studies that are not analysed at the 
same depth beneath the surface epithelium cannot be compared directly. Also, 
comparison of data from the different studies is complicated due to the varying 
approaches to uNK cell separation and purification, which is likely to lead to the 
inclusion of different cell types. Therefore comparisons cannot be made directly 
between different methodologies, for example flow cytometry and 
immunohistochemistry.  
 
Furthermore, the possibility that tissue disaggregation and cell purification may lead to 
cell activation should also be considered (50). This may explain the inconsistency 
between the results of NKp30 numbers and staining by the different studies.  
 
The advantages of using immunohistochemistry over other methods such as flow 
cytometry allowed location of uNK cells to be studied. However, it cannot be said with 
certainty that for example a cell stained positive for KI67 is definitely a CD56+ uNK cell. 
For this reason serial sequential sections were used to allow for comparisons to be 
made. However, this method is not very accurate since a cell’s diameter ranges 
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approximately from 5-15μm (198) and therefore the same cell may not be identifiable 
on the next serial section micrograph if it is only 5μm in diameter as each section used 
in this study was 4μm. 
 
To overcome this problem double staining was also carried out on a small selection of 
the endometrial samples to determine whether a CD56+ cell was also a KI67+ cell. This 
is illustrated by the micrographs in figure 18. As demonstrated by the micrographs, it is 
difficult to determine the structures, such as vessels and glands of the endometrium. 
Again, this makes it difficult to determine the distribution of uNK cells across different 
locations. 
 
   
 
Fig 18: The micrographs above show double staining from, A- A high uNK cell density patient and B- A 
low uNK cell density patient. The brown staining represents CD56 and the grey staining represents KI67. 
As seen on the micrographs it is difficult to appreciate any structures within the endometrium. Also 
double staining cannot be seen clearly.   
A B 
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5.2 CLINICAL IMPLICATIONS OF RESULTS 
 
The results of the current study have provided more data to that already published to 
show us that uNK cells are a unique subset of natural killer cells that are solely 
confined to the endometrium. From the following results and that of previous studies, 
it can be said that there is little scientific justification for testing peripheral blood for 
pbNK cells to identify the cause of RM. As this investigation does not reflect what 
pathology is going on in the endometrium. The biologically important tissue is the 
endometrium, the site of implantation and the materno-foetal interface.  
 
Studying uNK cells at the different location sites has helped us determine the role of 
uNK cells to some extent.  Previous work found that uNK cell density correlated to 
endometrial vessel density (169) but this work raised the following question.   Are the 
uNK cell angiogenic cytokines causing vessel differentiation in the endometrial tissue? 
Alternatively, are the uNK cells in increased density because of increased vessel density 
and thus increased trafficking from the blood.  My study was designed to answer this 
question and the evidence all points to the former possibility,  that uNK cells  in the 
pre-implantation endometrium are proliferative, differentiated and thus influencing 
endometrial vessel development, as they were found to be differentiated and more 
proliferative around vessels. The CD56+ uNK cells were seen clustered around vessels 
at higher numbers compared to those in the epithelial edge and low stromal density 
areas.   
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5.3 FUTURE WORK  
 
Reproductive immunology advances has led to a more multidisciplinary approach to 
studying and treating couples with RM. The chance of a successful pregnancy in 
couples with unexplained RM together with the small number of data from 
randomised control trials means that clinicians should not use empirical treatments 
which may be of no benefit or may even cause harm. Instead, patients with RM should 
be recruited to an adequately powered placebo-controlled study. A trial is currently 
ongoing in the Liverpool Women’s Hospital where RM patients are receiving 
prednisolone or placebo. This trial will determine whether steroids increase the chance 
of a successful pregnancy outcome.  
 
The relationship between uNK cells and endometrial cytokine production also requires 
further investigation and how these processes may be defective in RM.  
 
The study has produced many interesting findings that could be investigated further. 
The uNK cell activating markers need to be looked at in more detail since we are the 
first to find the nuclear staining pattern of NKp30+ uNK cells. NKp30 should be looked 
at across the phases of the endometrium to determine whether the cells are 
differentiated differently at different stages and also whether they change from 
nuclear to cytoplasmic or vice versa.  This may help determine the role of uNK cells 
within the endometrium and their effect on pregnancy outcome.  
 
Other markers of trafficking could be examined to completely rule out the theory of 
NK cell migration from the blood.  
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Abstract submitted and accepted for a poster presentation for British Maternal 
and Foetal Medicine Society on 18-19/06/09.           
 
UNK CELLS IN PATIENTS WITH RECURRENT MISCARRIAGE SHOW EVIDENCE 
OF PROLIFERATION AND DIFFERENTIATION BUT NOT TRAFFICKING 
A  Karam, L Khan, J Drury, A W Tang, M Turner, S Quenby 
University of Liverpool, Liverpool, United Kingdom 
 
Introduction: There is considerable controversy concerning the origin of uterine 
natural killer cells (uNK).  There are two competing hypotheses. uNK cells could be the 
result of peripheral NK cells trafficking into the uterus or the result of proliferation of 
uNK cells in the endometrium. 
 
Method: Serial sequential sections of endometrial tissue from 20 recurrent miscarriage 
patients of extreme phenotype at  LH+7 days were stained using  
immunohistochemistry with antibodies to CD56, KI67, NKp30, L-Selectin and CD16, 
uNK cell markers of proliferation, differentiation and trafficking. Endometrium was 
examined using a single-blinded method and samples with high and low density of 
CD56+ cells were compared in areas of epithelium, oedema and vessels. 
 
Results: Preliminary semi-quantitative analysis showed more positively stained cells 
for all markers in samples with high-uNK cell density, except for CD16. The majority of 
CD56+ cells appeared to be CD16-. The CD56+ was seen more clustered around 
vessels.  
 
CD56 and NKp30 are frequently found nearer the epithelium in samples with high-uNK 
cell density. This sub-epithelial location is significant as it is where initial feto-maternal 
interaction occurs. The localisation of KI67 suggests that uNK cells surrounding 
vessels are the result of proliferation. The paucity of L-Selectin and CD16+ expression 
in either group suggests that uNK cells are not trafficking from peripheral blood. 
 
Conclusion: Preliminary data from recurrent miscarriage patients provides evidence of 
proliferation and differentiation of uNK cells but not trafficking from the peripheral 
circulation.  
 
Published as follows:  
 
A Karam, L Khan, J Drury, A Tang, M Turner, S Quenby. Uterine Natural Killer Cells In 
Patients With Recurrent Miscarriage Show Evidence Of Proliferation And Differentiation 
But Not Trafficking. Arch Dis Child Fetal Neonatal Ed 2009;94:Fa58-Fa71.  
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Abstract submitted and accepted for a poster presentation for Blair Bell Meeting 
on 05/11/09. 
 
THE ROLE AND ORIGINS OF UTERINE NATURAL KILLER (UNK) CELLS IN WOMEN WITH 
RECURRENT MISCARRIAGE (RM) 
A. Karam, L. Khan, A. Tang, J. Drury, M. Turner and S. Quenby 
 
Department of Reproductive and Developmental Medicine, University of 
Liverpool, Liverpool’s Women’s Hospital, Liverpool, L8 7SS 
 
Background: uNK cells are said to cause RM. However, the exact role and 
function of these unique cells is yet to be determined.  
 
Method: Immunohistochemical staining of endometrial sections from RM 
patients of extreme phenotype between LH +5-9 days. 20 RM patients 
analysed, 10 patients with high uNK density (≥ 5%) and 10 low uNK (≤ 2.5%). 
Samples were stained for antibodies to CD56, KI67, NKp30, L-Selectin and 
CD16, markers of proliferation, differentiation and trafficking. Epithelial edge, 
areas of low stromal cell density and peri-vascular stroma were studied.  
 
Results: High uNK had higher levels for all antibodies (P<0.0001). uNK were 
more proliferative and differentiated in high group and varied across location 
sites. Majority of uNK cells positive for CD56, KI67 and NKp30 were clustered 
around vessels (P=0.021, 0.001 and P=0.004 respectively).  
 
Conclusion: The paucity of L-Selectin+ and CD16+ in both groups suggests 
uNK are not trafficking from peripheral blood. The KI67+ and NKp30+ uNK assist 
angiogenesis of uterine arteries which increases blood flow and initiates 
oxidative stress in developing foetus causing RM.  
                     
 
 
  
 
                                            
  
 
 
